Hsbc Holdings PLC 6-K, filed Mar 25, 2022
Hsbc Holdings PLC (HSBC)
6-K
2022-03-25
For: 2022-03-25
View Original
Added on
July 07, 2026
About this 6-K
Hsbc Holdings PLC filed this 6-K on March 25, 2022.
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
For the
month of March
HSBC Holdings plc
42nd
Floor, 8 Canada Square, London E14 5HQ, England
(Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F).
Form
20-F X Form 40-F
(Indicate
by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities
Exchange Act of 1934).
Yes
No X
(If
"Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): 82-
).
The following regulated information, disseminated pursuant to
DTR6.3.5, comprises the Notice of Annual General Meeting for 2022
which was sent to shareholders of HSBC Holdings plc on 25 March
2022. A copy of the Notice of Annual General Meeting is available
at www.hsbc.com/agm.
HSBC Holdings plc
Notice of Annual General Meeting to be held at 11.00am London
time
(6.00pm Hong Kong time) on Friday, 29 April 2022
Queen Elizabeth Hall, Southbank Centre, Belvedere Road, London, SE1
8XX
Facilities will be made available to allow shareholders to attend,
participate and vote electronically at the AGM and to ask questions
in real time should they wish to do so.
Further information on how to join the meeting electronically can
be found on pages 19 to 20.
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE
ATTENTION.
If you are in any doubt as to any aspect of the proposals referred
to in this document or as to the action you should take, you should
consult a stockbroker, solicitor, accountant or other appropriate
independent professional adviser.
If you have sold or transferred all of your shares in HSBC Holdings
plc (the "Company" or "HSBC" and together with its subsidiary
undertakings, the "Group") you should at once forward this document
and all accompanying documents to the stockbroker, bank or other
agent through whom the sale or transfer was effected for
transmission to the purchaser or transferee.
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of
Hong Kong Limited take no responsibility for the contents of this
document, make no representation as to its accuracy or completeness
and expressly disclaim any liability whatsoever for any loss
howsoever arising from or in reliance upon the whole or any part of
the contents of this document. The ordinary shares of the Company
trade under stock code 5 on The Stock Exchange of Hong Kong
Limited.
A Chinese translation of this Notice of Annual General Meeting is
available at www.hsbc.com/agm. Alternatively, the Chinese
translation of this and future documents may be obtained by
contacting the Company's registrar (see page 20).
Contents
1. Chairman's
letter
3. Directors'
Biographies
6. Notice of
the 2022 Annual General Meeting and Explanatory
notes
|
|
|
|
|
|
1.
|
Annual Report & Accounts
|
|
|
2.
|
Directors' Remuneration Report
|
|
|
3.
|
Directors' Remuneration Policy
|
|
|
4.
|
Election and re-election of Directors
|
|
|
5.
|
Re-appointment of Auditor
|
|
|
6.
|
Remuneration of Auditor
|
|
|
7.
|
Political Donations
|
|
|
8.
|
Authority to allot shares
|
|
|
9.
|
Disapplication of pre-emption rights
|
|
|
10.
|
Further disapplication of pre-emption rights for
acquisitions
|
|
|
11.
|
Addition of any repurchased shares to general authority to allot
shares
|
|
|
12.
|
Purchases of Ordinary Shares by the Company
|
|
|
13.
|
Approval of form of share repurchase contract
|
|
|
14.
|
Additional authority to allot equity securities in relation to the
issue of Contingent Convertible Securities
|
|
|
15.
|
Limited disapplication of pre-emption rights in relation to the
issue of Contingent Convertible Securities
|
|
|
16.
|
Renewal of scrip dividend authority
|
|
|
17.
|
Amendments to Articles of Association
|
|
|
18.
|
Notice of general meetings
|
|
|
19.
|
Shareholder requisitioned resolution - Midland Clawback
Campaign
|
|
|
|
|
16. Information about the
2022 Annual General Meeting
19. Electronic attendance
at the 2022 Annual General Meeting
20. General
information
21.
Appendices
Chairman's letter
Dear Shareholder
Mark E Tucker
Group Chairman
I am pleased to invite you to the HSBC Holdings plc 2022 Annual
General Meeting ("AGM") which will be held on Friday, 29 April 2022
at 11.00am London time (6.00pm Hong Kong time) at the Queen
Elizabeth Hall, Southbank Centre, Belvedere Road, London, SE1
8XX.
I look forward to seeing many of you at our AGM. If, however, you
are unable to attend in person, you will also be able to attend,
vote and raise questions electronically using the platform provided
by following the instructions set out on pages 19 to 20. A
telephone line will also be provided as an additional means for you
to ask questions at the AGM. This can be accessed by following the
instructions set out on page 20.
Please read the enclosed Notice of AGM which explains the business
to be considered at the AGM. In addition to the standard items of
business, I would specifically like to highlight the following
items:
Directors
There have been a number of changes to the membership of the Board
since last year's AGM.
Two new independent non-executive Directors have joined the
Board:
− Rachel Duan joined the Board on 1 September 2021.
Rachel is a highly regarded and experienced business leader who
brings significant Asia and international leadership experience and
business acumen to the Board; and
− Dame Carolyn Fairbairn joined the Board on 1
September 2021. Carolyn is a highly regarded business leader with a
deep understanding of the macro-economic and political environment
and has strong experience in media, government and
finance.
In line with best practice and as required by the Articles of
Association, Rachel and Carolyn will stand for election for the
first time at this year's AGM. All other continuing Directors will
stand for re-election.
On 26 January 2022, we announced that Pauline van der Meer Mohr and
Irene Lee would retire from the Board at the conclusion of this
year's AGM. Pauline and Irene have made valuable contributions to
both the Board and the Committees on which they have served during
their tenure. We wish them well with their future endeavours. Irene
Lee will remain on the Boards of the following Company's
subsidiaries, as an independent non-executive Director of The
Hongkong and Shanghai Banking Corporation Limited and independent
non-executive Chair of Hang Seng Bank Limited.
The Board considers that each of the Directors standing for
election or re-election continues to make a strong contribution to
the Board and its Committees through their skills and experience.
Further information can be found in their biographies on pages 3 to
5. All of the Directors were subject to a performance review and I
held individual discussions with each of them during the year.
Further details can be found in the Annual Report & Accounts in
respect of the year ended 31 December 2021 ("2021 Annual Report
& Accounts").
At the conclusion of this year's AGM, subject to the election and
re-election of the Directors as recommended, your Board will
comprise a non-executive Group Chairman, two executive Directors
and eight independent non-executive Directors.
Directors' Remuneration Policy
In 2019, you approved our remuneration policy which has been in
force since that time but which expires at the end of its fixed
three-year term at the 2022 AGM ("2019 Directors' Remuneration
Policy"). Accordingly, at this year's AGM, as set out in the 2021
Directors' remuneration report on pages 254 to 287 of the 2021
Annual Report & Accounts ("2021 Directors' Remuneration
Report"), the Group Remuneration Committee is recommending your
approval of a new Directors' remuneration policy ("2022 Directors'
Remuneration Policy").
The 2021 Directors' Remuneration Report, which you will also be
invited to approve, comprises a report by the Group Remuneration
Committee on its implementation of the 2019 Directors' Remuneration
Policy during 2021.
Amendments to Articles of Association
We are proposing amendments to the Company's Articles of
Association under Resolution 17(a), principally to reflect
developments in market practice and to provide clarification and
additional flexibility to the Company where necessary or
appropriate. A new article (proposed as a separate special
resolution, Resolution 17(b)) will also make it clear that certain
claims involving the Company, its subsidiaries and/or its or their
current or former directors, officers and employees should be
determined in the English or Hong Kong courts.
Details of the proposed changes can be found in Appendix 3 and 4 on
pages 24 to 25.
Share buy-back resolution
In addition to the usual share buy-back resolution, this year we
are proposing an additional share buy-back resolution to allow the
Company to make off-market purchases on The Stock Exchange of Hong
Kong Limited. Having the ability to run a share buy-back in Hong
Kong will allow us to access more of the HSBC trading volume and
should help to quicken the completion of our share buy-back
programmes.
Shareholder requisitioned resolution - Midland Clawback
Campaign
We have received notice of a shareholder requisitioned resolution
pursuant to Section 338 of the UK Companies Act 2006 from the
Midland Clawback Campaign. This resolution is incorporated as
Resolution 19 in the Notice of AGM. The resolution and supporting
statement (which is set out in Appendix 5 on page 26) should be
read together.
Your Board recommends that you vote AGAINST this resolution for the reasons set out in
Appendix 6 on pages 26 to 28.
Your Board considers that the proposals set out in Resolutions 1 to
18 of this Notice are in the best interests of the Company and its
shareholders, and recommends that you vote in favour of these
resolutions. Your Board recommends that you vote AGAINST Resolution
19 for the reasons set out in Appendix 6 on pages 26 to
28. The Directors intend
to vote in line with these recommendations in respect of their own
beneficial holdings except in relation to Resolution 3, regarding
the 2022 Directors' Remuneration Policy where the Directors will
not vote due to their interest in the policy.
A form of proxy is enclosed or can be accessed at
www.hsbc.com/proxy. I encourage you to vote on the Resolutions
in advance of the AGM by completing and submitting a form of proxy
appointing the Chairman of the AGM as your proxy. This is to ensure
that your vote is counted even if you plan to attend
electronically. Appointing a proxy will not prevent you from
attending the AGM electronically or physically and voting on the
day.
Together with the Board, I would like to thank you - our valued
shareholders - for your continued support and I very much look
forward to being able to welcome you to the AGM.
Yours sincerely
Mark E Tucker
Group Chairman
25 March 2022
HSBC Holdings plc
Incorporated in England with limited liability.
Registered in England: number 617987
Registered Office and Group Head Office:
8 Canada Square, London E14 5HQ, United Kingdom
Directors' Biographies
Brief biographical details of each Director standing
for election and re-election are set out below.
Non-executive
Group Chairman
Mark Edward Tucker (64)
Group Chairman
Appointed to the Board: September 2017
Group Chairman since: October 2017
Committee Membership: Nomination & Corporate Governance
Committee (Chair)
Skills and experience: With over 35 years of experience in financial
services in Asia, Africa, the US and the UK, including 25 years
based in Hong Kong, Mark has a deep understanding of the industry
and markets in which we operate.
Career: Mark was most
recently Group Chief Executive and President of AIA Group Limited
('AIA'), having joined in July 2010. Prior to AIA, he was Group
Chief Executive of Prudential plc. He served on Prudential's Board
for nearly 10 years. Mark previously served as non-executive
Director of the Court of the Bank of England and as an independent
non-executive Director of Goldman Sachs Group.
External appointments: Chair of TheCityUK, non-executive Chair of
Discovery Limited, Co-Chair of the B20 Finance and Infrastructure
Task Force (Indonesia 2022), Director, Peterson Institute for
International Economics, Director, Institute of International
Finance, International Adviser to the Hong Kong Academy of Finance,
Member of the Asia Society Board of Trustees, Member of the UK
Investment Council and Supporting Chair of Chapter
Zero.
Reasons for re-election: Mark has a wealth of leadership experience
within financial services in Asia and the UK, through his roles
with Prudential and AIA. His knowledge of our markets and extensive
experience as a leader, non-executive Director and Chairman, in
addition to his geographical and stakeholder insights, position him
well to lead the Board.
Executive Directors
Noel Paul Quinn (60)
Group Chief Executive
Appointed to the Board: August 2019
Group Chief Executive since: March 2020
Skills and experience: Having qualified as an accountant in
1987, Noel has more than 30 years of banking and
financial services experience, both in the UK and
Asia.
Career: Noel was formally
named Group Chief Executive in March 2020, having held the role on
an interim basis since August 2019. He has held various roles
across HSBC, or its constituent companies, since 1987. Prior to
becoming Group Chief Executive, Noel was most recently CEO, Global
Commercial Banking. He has also served as Regional Head of
Commercial Banking for Asia-Pacific, Head of Commercial Banking UK,
Head of Commercial Finance Europe, and Group Director of Strategy
and Development at HSBC Insurance Services North
America.
External appointments: Chair of the Financial Services Task Force
of HRH The Prince of Wales' Sustainable Markets Initiative, Member
of the Principals Group of the Glasgow Financial Alliance for Net
Zero and Member of the World Economic Forum's International
Business Council.
Reasons for re-election: Noel's comprehensive banking and financial
services background provides the foundation for his role as Group
Chief Executive. His knowledge and experience, as well as his
proven track record with HSBC across leadership and strategic roles
based in the UK and Asia, provides the platform for him to deliver
the Group's strategy.
Ewen James Stevenson (55)
Group Chief Financial Officer
Appointed to the Board: January 2019
Skills and experience: Ewen has over 25 years of experience in the
banking industry as an adviser and executive to major banks and
large financial institutions. In addition to his existing
leadership responsibilities for Group Finance, Ewen assumed
responsibility for the oversight of the Group's transformation
programme in February 2021 and the Group's corporate development
activities in April 2021.
Career: Ewen was Chief
Financial Officer at the Royal Bank of Scotland Group plc from 2014
to 2018. Before this, Ewen spent 25 years with Credit Suisse, where
his last role was co-Head of the EMEA Investment Banking Division
and co-Head of the Global Financial Institutions
Group.
External appointments: Non-executive Director of The Hongkong and
Shanghai Banking Corporation Limited.
Reasons for re-election: Ewen's comprehensive background within the
banking and financial industry, including advisory and leadership
roles, helps ensure strong financial management to achieve the
Group's strategy.
Independent non-executive Directors
Rachel Duan (51)
Independent non-executive Director
Appointed to the Board: September 2021
Committee Membership: Group Remuneration Committee and Nomination
& Corporate Governance Committee
Skills and experience: Rachel is a business leader with exceptional
international experience in the US, Japan, mainland China and Hong
Kong.
Career: Rachel spent 24
years at General Electric ('GE'), most recently as Senior Vice
President of GE, and President and Chief Executive Officer of GE's
Global Markets, where she was responsible for driving GE's growth
in Asia Pacific, the Middle East, Africa, Latin America, and Russia
and the Commonwealth of Independent States. She has also previously
served as President and Chief Executive Officer of GE Advanced
Materials China and then of the Asia-Pacific, President and CEO of
GE Healthcare China, and President and CEO of GE
China.
External appointments: Independent Director of the Adecco Group, of
AXA S.A. and of Sanofi S.A.
Reasons for election: Rachel brings invaluable input to the
Board's discussions and decision-making through her extensive
knowledge and experience of two of the Group's most strategically
important markets - Hong Kong and mainland
China.
Dame Carolyn Fairbairn (61)
Independent non-executive Director
Appointed to the Board: September 2021
Committee Membership: Group Remuneration Committee, Group Risk
Committee and Nomination & Corporate Governance
Committee
Skills and experience: Carolyn has significant experience across
the media, government and finance sectors.
Career: An economist by
training, Carolyn has served as a Partner at McKinsey &
Company, Director-General of the Confederation of British Industry,
and Group Development and Strategy Director at ITV plc. She has
extensive board experience, having previously served as
non-executive Director of Lloyds Banking Group plc, the Vitec Group
plc and Capita plc. She has also served as a non-executive Director
of the UK Competition and Markets Authority and the Financial
Services Authority.
External appointments: Non-executive Director of BAE Systems
plc.
Reasons for election: Carolyn has a deep understanding of the
macroeconomic and political environment, particularly in the UK,
from her time as the Director-General of the Confederation of
British Industry. She also has extensive FTSE board experience in
the UK, and has in-depth knowledge and experience of the governance
and regulatory environment in which the Group
operates.
James Anthony Forese (59)
Independent non-executive Director
Appointed to the Board: May 2020
Committee Membership: Group Audit Committee, Group Remuneration
Committee and Nomination & Corporate Governance
Committee
Skills and experience: James has over 30 years of international
business and management experience in the finance
industry.
Career: James formerly
served as President of Citigroup. He began his career in securities
trading with Salomon Brothers, one of Citigroup's predecessor
companies, in 1985. In addition to his most recent role as
President, he was Chief Executive Officer of Citigroup's
Institutional Clients Group. He has also been Chief Executive of
its Securities and Banking division and head of its Global Markets
business.
External appointments: Non-executive Chair of Global Bamboo
Technologies and Trustee of Colby College. James is also the Chair
of the Group's US subsidiary, HSBC North America Holdings
Inc.
Reasons for re-election: James is an experienced executive with
wide-ranging leadership experience within the banking industry. His
experience of international business and management spans over
three decades and, as a non-executive Director, he contributes to
the Board through his deep experience of working in global markets,
investment and private banking.
Steven Craig Guggenheimer (56)
Independent non-executive Director
Appointed to the Board: May 2020
Committee Membership: Group Risk Committee and Nomination &
Corporate Governance Committee
Skills and experience: Steven brings extensive insight into technologies
ranging from artificial intelligence to Cloud computing, through
his experience advising businesses on digital
transformation.
Career: Steven has more
than 25 years of experience at Microsoft, where he held a variety
of senior leadership roles. These included Corporate Vice
President, Artificial Intelligence and Independent Software Vendor
Engagement; Corporate Vice President, Chief Evangelist; and
Corporate Vice President, Original Equipment
Manufacturer.
External appointments: Non-executive Director of Forrit
Technologies Limited, Independent Director of Software Acquisition
Group, Adviser to Tensility Venture Partners LLC and Advisory Board
Member of 5G Open Innovation Lab.
Reasons for re-election: Steven's career spans a number of management
and leadership roles within the technology sector. His valuable
contribution to the Board arises from his experience in delivering
cutting edge technology and the development of industry leading
applications and services globally. He brings unique perspectives
to the Board's deliberations.
Dr José Antonio Meade Kuribreña (53)
Independent non-executive Director
Appointed to the Board: March 2019
Committee Membership: Group Risk Committee, Group Remuneration
Committee and Nomination & Corporate Governance
Committee
Skills and experience: José has extensive experience in public
administration, banking, financial policy and foreign
affairs.
Career: José has held
Cabinet-level positions in the federal government of Mexico,
including as Secretary of Finance and Public Credit, Secretary of
Social Development, Secretary of Foreign Affairs and Secretary of
Energy. Prior to his appointment to the Cabinet, he served as
Undersecretary and as Chief of Staff in the Ministry of Finance and
Public Credit. José is also a former Director General of
Banking and Savings at the Ministry of Finance and Public Credit,
and served as Chief Executive Officer of the National Bank for
Rural Credit.
External appointments: Board Member of The Global Center on
Adaptation, non-executive Director of Alfa S.A.B. de C.V. and Grupo
Comercial Chedraui, S.A.B. de C.V. Member of the Independent Task
Force on Creative Climate Action and Member of the UNICEF Mexico
Advisory Board.
Reasons for re-election: José has a wealth of experience in
public administration, banking and financial policy. In addition to
this, he has connectivity to the Mexican market and provides
invaluable enhancement to the Board's knowledge and experience in
this region.
Eileen K Murray (64)
Independent non-executive Director
Appointed to the Board: July 2020
Committee Membership: Group Risk Committee and Nomination &
Corporate Governance Committee
Skills and experience: Eileen has extensive knowledge in financial
technology and corporate strategy from a career spanning more than
40 years.
Career: Eileen most
recently served as co-Chief Executive Officer of Bridgewater
Associates, LP. Before this, she was Chief Executive Officer for
Investment Risk Management LLC and President and co-Chief Executive
Officer of Duff Capital Advisors. Eileen started her professional
career at Morgan Stanley, having held positions including
Controller, Treasurer, and Global Head of Technology and
Operations, as well as Chief Operating Officer for its
Institutional Securities Group. At Credit Suisse, she was Head of
Global Technology, Operations and Product
Control.
External appointments: Chair of the Financial Industry Regulatory
Authority, non-executive Director of Guardian Life Insurance
Company of America, and adviser of ConsenSys, Aquarion Company and
of Invisible Urban Charging.
Reasons for re-election: Eileen has significant finance, technology
and transformation experience in the banking sector. This
experience, alongside a detailed understanding of regulatory
requirements and comfort with a breadth of financial products,
means that she is able to bring important insights to Board
discussions.
David Thomas Nish (61)
Independent non-executive Director
Appointed to the Board: May 2016
Senior Independent non-executive Director since: February
2020
Committee Membership: Group Audit Committee (Chair), Group Risk
Committee and Nomination & Corporate Governance
Committee
Skills and experience: David has international experience in
financial services, corporate governance, financial accounting, and
strategic and operational transformation.
Career: David served as
Group Chief Executive Officer of Standard Life plc between 2010 and
2015, having joined the company in 2006 as Group Finance Director.
He is also a former Group Finance Director of Scottish Power plc
and was a partner at Price Waterhouse. David has also previously
served as a non-executive Director of HDFC Life (India), Northern
Foods plc, London Stock Exchange Group plc, the UK Green Investment
Bank plc and Zurich Insurance Group.
External appointments: Non-executive Director of Vodafone Group plc
and Honorary Professor of Dundee University Business
School.
Reasons for re-election: David is an experienced executive and
non-executive Director, having held a number of board appointments
across a variety of sectors, including insurance and asset
management. He adds to the Board discussion through his experience
in delivering significant performance improvements, delivering
strategic change and in financial accounting. His extensive
experience in stakeholder management and financial accounting means
that he is well placed to act as our Senior Independent
non-executive Director and to lead the Group Audit
Committee.
Jackson Peter Tai (71)
Independent non-executive Director
Appointed to the Board:
September 2016
Committee Membership: Group Risk Committee (Chair), Group Audit
Committee and Nomination & Corporate Governance
Committee
Skills and experience: Jackson has held senior operating and governance
roles across Asia, North America and Europe.
Career: Jackson was Vice
Chairman and Chief Executive Officer of DBS Group and DBS Bank
Ltd., having served as Chief Financial Officer and then as
President and Chief Operating Officer. He worked for 25 years with
J.P. Morgan & Co. Incorporated, holding roles as Chairman of
Asia-Pacific Management Committee and Head of Japan
Capital Markets. Other former appointments included non-executive
Director of Canada Pension Plan Investment Board, Royal Philips
N.V., Bank of China Limited, Singapore Airlines, NYSE Euronext, ING
Groep N.V., CapitaLand Ltd, SingTel Ltd. and Jones Lang LaSalle
Inc. He also served as Vice Chairman of Islamic Bank of
Asia.
External appointments: Non-executive Director of Eli Lilly and Company and of
MasterCard Incorporated.
Reasons for re-election: In addition to a distinguished career in
investment banking, Jackson is an experienced director who has held
a number of non-executive and committee chair roles on various
international boards. He has deep expertise of operating within
Asia. He provides the Board with valuable contribution as Chair of
the Group Risk Committee as well as on financial and strategic
matters.
Save as disclosed above and in Appendix 7 there are no further
matters or particulars required to be disclosed pursuant to Rule
13.51(2) of the Rules Governing the Listing of Securities on The
Stock Exchange of Hong Kong Limited ("Hong Kong Listing
Rules").
HSBC Holdings plc
Notice of the 2022 Annual General Meeting and Explanatory
Notes
Notice is hereby given that the 2022 Annual General Meeting of HSBC
Holdings plc will be held at the Queen Elizabeth Hall, Southbank
Centre, Belvedere Road, London, SE1 8XX, United Kingdom on Friday,
29 April 2022 at 11.00am London time (6.00pm Hong Kong time)
in accordance with the information set out on pages 16 to 20
and in Appendix 8 on page 29.
Resolutions numbered 1 to 8, 11, 14 and 16 will be proposed as
ordinary resolutions and those numbered 9, 10, 12, 13, 15 and 17 to
19 will be proposed as special resolutions. For ordinary
resolutions to be passed, more than half of the votes cast must be
in favour of the resolution, while in the case of special
resolutions to be passed, at least three-quarters of the votes must
be cast in favour of the resolution.
The explanatory notes should be read in conjunction with the 2021
Annual Report & Accounts. This Notice of AGM, the 2021 Annual
Report & Accounts and the 2021 Strategic Report are available
at www.hsbc.com.
For the purpose of this Notice, the issued share capital (excluding
treasury shares) of the Company on 10 March 2022, being the latest
practicable date prior to the printing of this document, was
20,213,994,492 ordinary shares of US$0.50 each and carrying one
vote each with total voting rights of 20,213,994,492.
|
1. Annual Report & Accounts*
To receive the Annual Accounts and Reports of the Directors and of
the Auditor for the year ended 31 December 2021.
|
The purpose of this resolution is for shareholders to receive and
consider the Annual Accounts and the Reports of the Directors and
of the Auditor for the year ended 31 December 2021.
|
2. Directors' Remuneration Report*
To approve the 2021 Directors' Remuneration Report set out on pages
254 to 287 of the Annual Report & Accounts for the year ended
31 December 2021, excluding the 2022 Directors' Remuneration Policy
set out on pages 257 to 266.
|
The purpose of this resolution is to seek shareholder approval of
the 2021 Directors' Remuneration Report for the year ended 31
December 2021 (other than the part containing the 2022 Directors'
Remuneration Policy on pages 257 to 266 of the 2021 Annual Report
& Accounts). The 2021 Directors' Remuneration Report is on
pages 254 to 287 of the 2021 Annual Report & Accounts. The
actual remuneration paid to Directors in 2021 was made within the
boundaries of the 2019 Directors' Remuneration Policy which was
approved by shareholders at the 2019 Annual General Meeting. The
vote on the 2021 Directors' Remuneration Report is advisory in
nature and cannot impact what is paid under the
shareholder-approved 2019 Directors' Remuneration
Policy.
|
3. Directors' Remuneration Policy*
To approve the 2022 Directors' Remuneration Policy set out on pages
257 to 266 of the 2021 Directors' Remuneration Report contained
within the Annual Report & Accounts for the year ended 31
December 2021.
|
The purpose of this resolution is to seek shareholder approval of
the 2022 Directors' Remuneration Policy set out on pages 257 to 266
of the 2021 Directors' Remuneration Report in the 2021 Annual
Report & Accounts. This 2022 Directors' Remuneration Policy is
being presented as the term of our current 2019 Directors'
Remuneration Policy for Directors comes to an end at the 2022
AGM.
The 2022 Directors' Remuneration Policy is based on the following
key principles:
− the rationale and operation of the policy should
be easy to understand and transparent;
− there should be a strong alignment between rewards
and the interests of our stakeholders, including shareholders,
customers and employees;
− the policy should maintain a focus on long-term
performance;
− the total compensation package should be
competitive to ensure we can retain and attract talent to deliver
our strategic objectives; and
− the structure should meet the expectations of
investors and our regulators.
The Group Remuneration Committee undertook a detailed review of the
Group's remuneration policy during 2021 to assess whether it
continues to be appropriate based on the size and complexity of its
operations, investor feedback, best practice and market
developments. The Committee has become increasingly concerned that,
over time, the remuneration opportunity of our executive Directors
has fallen behind desired levels to reflect their calibre and
positioning against our international peers. This is supported by
benchmarked data for comparable roles in organisations similar in
size, geographical presence and with whom we compete for
talent.
The Group Remuneration Committee also noted that the UK regulatory
requirements restrict us from using a remuneration structure with a
greater focus on variable pay for performance, which is typically
used by our international peers.
The Group Remuneration Committee also noted the current policy and
its implementation have received strong support from shareholders
over the last few years. This was reaffirmed during engagement with
shareholders on the new policy. Based on the review and taking into
account the feedback received during the shareholder consultations,
we are proposing to roll forward our current policy for
shareholders' approval at the 2022 AGM.
The vote on the 2022 Directors' Remuneration Policy is by way of
ordinary resolution. It is a binding vote, meaning that, if
approved, payments to Directors may only be made if they are within
the boundaries of the policy.
The policy sets out how the Company proposes to pay the Directors,
including every element of remuneration to which a Director may be
entitled, as well as how the policy supports the Company's
long-term strategy and performance. It also includes details of the
Company's approach to recruitment and payment for loss of
office.
If the Company wishes to make changes to its remuneration policy,
it has to put a new policy to shareholders for approval at a
general meeting. Once approved, the Company will only be able to
make remuneration payments to current and prospective Directors and
payments for loss of office to current or past Directors within the
boundaries of the new policy, unless the payment is approved by a
separate shareholder resolution.
If approved by shareholders, the policy will apply for a three-year
term from the conclusion of the AGM. We will keep the issues on
appropriate positioning of our executive Directors' total
remuneration opportunity under review throughout the duration of
the policy.
Given the interests of the Directors in the remuneration policy,
the Directors will not vote on this resolution.
|
4. Election and re-election of
Directors*
To elect by separate resolutions each of:
(a) Rachel Duan;
(b) Dame Carolyn Fairbairn;
To re-elect by separate resolutions each of:
(c) James Forese;
(d) Steven Guggenheimer;
(e) Dr José Antonio Meade Kuribreña;
(f) Eileen Murray;
(g) David Nish;
(h) Noel Quinn;
(i) Ewen Stevenson;
(j) Jackson Tai; and
(k) Mark E Tucker.
|
Directors' biographies
Brief biographical details of each of the Directors standing for
election and re-election are set out set out on pages 3 to
5.
Appointment
Appointments to the Board are made on merit and candidates are
considered against objective criteria determined with reference to
the Board's skills matrix, having due regard to the benefits of
diversity in line with the Board's Diversity Policy. The Nomination
& Corporate Governance Committee (the "Committee") leads the
Board appointment process, agrees the criteria for any appointments
and engages independent external search consultants, as required.
At the conclusion of this process, the Committee nominates
potential candidates for appointment to the Board. In the exercise
of its responsibilities, the Committee regularly reviews the
Board's structure, size and composition, including skills,
knowledge, experience, independence and diversity.
Diversity
The biography of each Director located on pages 3 to 5 can be used
to assess how each individual contributes to the diversity of the
Board.
Independence
The Board has concluded that all of the non-executive Directors
standing for election or re-election at the AGM are independent in
character and judgement.
When considering independence, the Board calculates the length of
service of a non-executive Director by reference to the date of his
or her election by shareholders following his or her appointment.
The Board has determined that there are no relationships or
circumstances which are likely to affect the judgement of any of
the non-executive Directors. Any relationships or circumstances
which could appear to do so are not considered to be material. Each
of the Directors standing for election or re-election has confirmed
that they have no material relationship with another Director, a
member of senior management or any substantial or controlling
shareholder of the Company.
Election of new Directors
The following Directors were each appointed as a non-executive
Director of the Company during the year and will offer themselves
for election as non-executive Directors at this AGM:
− Rachel Duan (with effect from 1 September 2021);
and
− Dame Carolyn Fairbairn (with effect from 1
September 2021).
Time commitment
The Board, both prior to a Director's appointment and when
nominating a Director for election or re-election, enquires and
obtains assurance, that each Director is, or will be, capable of
contributing the time expected of them and time that may be
unanticipated should additional demands be placed on them in
relation to HSBC or in relation to their other
commitments.
The Board has carefully considered the other commitments held
by the Directors and has applied the same standard of enquiry for
each of them. Our focus is to determine the ability of each
Director to commit sufficient time to fulfil their individual
obligations, rather than a strict adherence to a numeric count of
directorships. Where Directors hold other roles either outside of
or elsewhere within the Group, or prior to accepting any additional
roles, particular attention is paid to ensure that they are able to
commit sufficient time to the Company.
Eileen Murray was unable to attend meetings in the last few months
of 2021 due to personal health reasons, but was kept informed of
Board and relevant Committee matters. She was fully briefed ahead
of her return to regular meeting attendance in January 2022. Eileen
continues to have sufficient time to dedicate to her role with
HSBC.
Tenure
Non-executive Directors are appointed for an initial three-year
term and, subject to re-election by shareholders at each AGM, are
typically expected to serve two three-year terms. The Board may
invite a Director to serve additional periods. Any term beyond six
years is subject to a particularly rigorous review by the
Committee, with any appointment beyond six years to be for one-year
terms only.
The biographies on pages 3 to 5 set out the skills and experience
which underpin the contribution each Director brings to the Board
for the long term sustainable success of the Company. Based upon
the review undertaken, the Board has satisfied itself that each of
the Directors is fully able to discharge their duties to the
Company and that they each have sufficient capacity to meet their
commitments to the Company. The Board has therefore concluded that
all of the Directors should offer themselves for election or
re-election in accordance with the Group's regular practice. Irene
Lee and Pauline van der Meer Mohr are retiring at the conclusion of
the AGM and are not offering themselves for
re-election.
|
|
|
Fees(per annum)
|
|
|
||
|
Committee*
|
|
Chairman
|
|
Member
|
|
Committee members standing for
election or re-election**
|
|
Group Audit Committee
|
|
£75,000
|
|
£40,000
|
|
David Nish (Chairman), James Forese and Jackson Tai
|
|
Group Risk Committee
|
|
£150,000
|
|
£40,000
|
|
Jackson Tai (Chairman), Dame Carolyn Fairbairn, Steven
Guggenheimer, Dr José Antonio Meade Kuribreña, Eileen
Murray and David Nish
|
|
Group Remuneration Committee***
|
|
£75,000
|
|
£40,000
|
|
Rachel Duan, Dame Carolyn Fairbairn, James Forese and Dr José
Antonio Meade Kuribreña
|
|
Nomination & Corporate Governance Committee
|
|
N/A****
|
|
£33,000
|
|
Mark E Tucker (Chairman), Rachel Duan, Dame Carolyn Fairbairn,
James Forese, Steven Guggenheimer, Dr José Antonio Meade
Kuribreña, Eileen Murray, David Nish and Jackson
Tai
|
|
Technology Governance Working Group
|
|
£60,000
|
|
£30,000
|
|
Eileen Murray (co-Chair), Steven Guggenheimer (co-Chair) and
Jackson Tai
|
* For further details of the
roles and accountabilities of each of these Board Committees, see
pages 237 to 287 of the 2021 Annual Report &
Accounts.
** The table does not include Committee members
retiring and not standing for re-election at the AGM.
*** The Group
Remuneration Committee Chairman is currently Pauline van der Meer
Mohr who is not standing for re-election at the AGM.
**** The Group Chairman serves
as the Chairman of the Nomination & Corporate Governance
Committee and receives no additional fee in respect of this
position.
Non-executive Directors' fees
Subject to shareholder approval of the new 2022 Directors'
Remuneration Policy under Resolution 3 at the 2022 Annual General
Meeting, each non-executive Director will receive a fee of
£127,000 per annum. The Senior Independent non-executive
Director will receive a fee of £200,000 per annum in addition
to his non-executive Director fee and the fees payable for the
Chairmanship or membership of Board Committees. The non-executive
Group Chairman will receive a fee of £1.5 million per
annum.
The fees paid to non-executive Directors who are standing for
election or re-election as members of Board Committees are set out
in the table on page 7 (these Board Committees' fees and Board fees
are pro-rated for part year service where relevant).
The Technology Governance Working Group is an informal committee of
the Board, providing recommendations to enhance the Board's
oversight of technology strategy, governance and emerging risks and
enhance connectivity with the principal subsidiaries. The working
group is jointly chaired by Eileen Murray and Steven Guggenheimer,
using their industry expertise and experience. Its members include
Group Risk Committee Chairman Jackson Tai and other non-executive
Directors representing each of our US, UK, European and Asian
principal subsidiaries. The total time commitment expected of the
co-Chairs is up to 30 days, reflective of the complexity and
profile of the subject matter. The Board has determined a fee of
£60,000 for each of the co-Chairs. Members receive a fee of
£30,000.
Following his appointment as Chairman of HSBC North America
Holdings Inc during 2021, James Forese receives an annual fee of
US$550,000. These fees were approved by the shareholder and
authorised by the Board of HSBC North America Holdings
Inc.
Non-executive Directors also receive a travel allowance of
£4,000 per annum towards the additional time commitment
required for travel. During periods when the Board is unable to
travel, non-executive Directors will not receive this
allowance.
Non-executive Directors' terms of appointment
Non-executive Directors do not have service agreements, but are
bound by letters of appointment issued for and on behalf of the
Company. Subject to their re-election by shareholders, the terms of
appointment of the non-executive Directors will expire at the
conclusion of the Annual General Meetings held in the following
years: David Nish and Jackson Tai - 2023; Mark E Tucker, James
Forese, Steven Guggenheimer and Eileen Murray - 2024; and Dr
José Antonio Meade Kuribreña, Rachel Duan and Dame
Carolyn Fairbairn - 2025.
Executive Directors' service contracts and
remuneration
The executive Directors have rolling service contracts with a
notice period of 12 months for either party. The dates of the
service contracts are:
Noel Quinn 18 March
2020
Ewen Stevenson 1 December 2018
Under the terms of their employment, Noel Quinn and Ewen Stevenson
each receive fixed pay consisting of base salary, cash in lieu of
pension and fixed pay allowance and are eligible to receive
discretionary variable pay awards.
From 1 March 2022, their base salaries increased by 3.5% per cent
in line with base salary increase for Group employees to
£1,336,000 and £779,000 per annum respectively. Noel
Quinn and Ewen Stevenson receive cash in lieu of pension allowance
at 10 per cent of base salary. Fixed pay allowances delivered in
shares (net of shares sold to cover any income tax and social
security) will be subject to a retention period. Shares will be
released annually on a pro rata basis over five years starting from
the March immediately following the end of the financial year in
respect of which the shares are granted. The fixed pay allowance
paid to Noel Quinn is £1,700,000 per annum and for Ewen
Stevenson is £1,085,000 per annum.
Further details of the Directors' emoluments are set out in the
2021 Directors' Remuneration Report contained in the 2021 Annual
Report & Accounts on pages 254 to 287.
The Directors at the date of this document are: Rachel Duan†,
Carolyn Julie Fairbairn†, James Anthony Forese†, Steven
Guggenheimer†, Irene Lee†, José Antonio Meade
Kuribreña†, Eileen K Murray†, David Nish†,
Noel Quinn, Ewen Stevenson, Jackson Tai†, Mark Tucker*, and
Pauline van der Meer Mohr†.
* Non-executive Group Chairman
† Independent non-executive Director
|
5. Re-appointment of Auditor*
|
To re-appoint PricewaterhouseCoopers LLP as Auditor of the Company,
to hold office from the conclusion of this meeting until the
conclusion of the next general meeting of the Company at which
accounts are laid.
The current appointment of PricewaterhouseCoopers LLP ("PwC") as
Auditor of the Company terminates at the conclusion of this year's
AGM.
PwC has expressed its willingness to continue in office. The Group
Audit Committee and the Board have recommended that PwC be
re-appointed until the conclusion of the next general meeting of
the Company at which accounts are laid.
|
6. Remuneration of Auditor*
To authorise the Group Audit Committee to determine the
remuneration of the Auditor.
|
The Directors may set the remuneration of the Auditor if authorised
to do so by the shareholders. The Board have recommended that the
Group Audit Committee be authorised to determine the remuneration
of PwC. This Resolution seeks authority for the Group Audit
Committee to set the remuneration of the Auditor for 2022. An
analysis of the remuneration paid in respect of audit and non-audit
services provided by our Auditor and their affiliates for each of
the past three years is disclosed on page 337 in the 2021 Annual
Report & Accounts.
|
7. Political Donations*
THAT in accordance with sections 366 and 367 of the UK Companies
Act 2006 (the "Act") the Company, and any company which is a
subsidiary of the Company at any time during the period for which
this resolution has effect, be authorised to:
(a) make political donations to political parties
and/or independent election candidates, not exceeding £200,000
in total;
(b) make political donations to political organisations
other than political parties, not exceeding £200,000 in total;
and
(c) incur political expenditure, not exceeding
£200,000 in total,
in each case during the period starting on the date of the passing
of this Resolution 7 and expiring at the conclusion of the Annual
General Meeting of the Company to be held in 2023 or at the close
of business on 30 June 2023, whichever is earlier, provided the
aggregate amount of any such donations and expenditure shall not
exceed £200,000 during the period for which this Resolution 7
has effect. For the purposes of this resolution, the terms
'political donations', 'political parties', 'independent election
candidates', 'political organisations' and 'political expenditure'
shall have the meanings given to them by sections 363 to 365 of the
Act.
|
The UK Companies Act 2006 (the "Act") requires companies to obtain
shareholder authority for donations to registered political parties
and other political organisations, totalling more than £5,000
in any 12 month period and for any political expenditure, subject
to limited exceptions.
In accordance with Group policy, HSBC does not make any political
donations or incur political expenditure within the ordinary
meaning of those words. We have no intention of altering this
policy. However, the definitions of political donations, political
parties, political organisations and political expenditure used in
the Act are very wide. As a result, they may cover routine
activities that form part of the normal business activities of the
Group and are an accepted part of engaging with stakeholders to
ensure that issues and concerns which affect the Group's operations
are considered and addressed, but which would not be considered as
political donations or political expenditure in the ordinary sense
of those words. Activities including contributions to or support
for bodies such as those concerned with policy review and law
reform or with the representation of the business community or
sections of it may be deemed to be political donations or
expenditure as defined by the Act. The activities referred to above
are not designed to influence public support for any political
party or political outcome. The authority is being sought on a
precautionary basis only to ensure that neither the Company nor any
of its subsidiaries inadvertently breaches the Act. Resolution 7
proposes a cap of £200,000 per category of political donation
or expenditure subject to an aggregate overall cap of £200,000
per annum for all such political donations and
expenditure.
If Resolution 7 is passed, this authority will be effective until
the conclusion of the 2023 Annual General Meeting or the close of
business on 30 June 2023, whichever is the earlier.
|
8. Authority to allot shares*
THAT the Directors be generally and unconditionally authorised
pursuant to and for the purposes of section 551 of the UK Companies
Act 2006 (the "Act") to exercise all the powers of the Company to
allot shares in the Company and to grant rights to subscribe for,
or to convert any security into, shares in the
Company:
(a) up to an aggregate nominal amount of
US$2,021,399,449 (such amount to be restricted to the extent that
any allotments or grants are made under paragraphs (b) or (c) of
this resolution so that in total no more than US$3,368,999,082 can
be allotted or granted under paragraphs (a) and (b) of this
resolution and no more than US$6,737,998,164 can be allotted under
paragraphs (a), (b) and (c) of this resolution); and
(b) up to an aggregate nominal amount of
US$3,368,999,082 (such amount to be restricted to the extent that
any allotments or grants are made under paragraphs (a) or (c) of
this resolution so that in total no more than US$3,368,999,082 can
be allotted or granted under paragraphs (a) and (b) of this
resolution and no more than US$6,737,998,164 can be allotted under
paragraphs (a), (b) and (c) of this resolution) in connection with
an offer or invitation to:
(i) holders of ordinary shares
in proportion (as nearly as may be practicable) to the respective
number of ordinary shares held by them; and
(ii) holders of other securities,
bonds, debentures or warrants which, in accordance with the rights
attaching thereto, are entitled to participate in such an offer or
invitation or as the Directors consider necessary,
but in each case subject to
such exclusions or other arrangements as the Directors may deem
necessary or expedient in relation to record dates, fractional
entitlements, treasury shares or securities represented by
depositary receipts or having regard to any restrictions,
obligations, practical or legal problems under the laws of or the
requirements of any regulatory body or stock exchange in any
territory or otherwise howsoever; and
(c) comprising equity securities (as defined in section
560 of the Act) up to an aggregate nominal amount of
US$6,737,998,164 (such amount to be restricted to the extent that
any allotments or grants are made under paragraphs (a) or (b) of
this resolution so that in total no more than US$6,737,998,164 can
be allotted under paragraphs (a), (b) and (c) of this resolution)
in connection with a rights issue to:
(i) holders of ordinary shares
in proportion (as nearly as may be practicable) to the respective
number of ordinary shares held by them; and
(ii) holders of other securities,
bonds, debentures or warrants which, in accordance with the rights
attaching thereto, are entitled to participate in such an issue or
as the Directors consider necessary,
but in each case subject to such
exclusions or other arrangements as the Directors may deem
necessary or expedient in relation to record dates, fractional
entitlements, treasury shares or securities represented by
depositary receipts or having regard to any restrictions,
obligations, practical or legal problems under the laws of or the
requirements of any regulatory body or stock exchange in any
territory or otherwise howsoever; and
(d) up to an aggregate nominal amount of £150,000 (in
the form of 15,000,000 non-cumulative preference shares of
£0.01 each), €150,000 (in the form of 15,000,000
non-cumulative preference shares of €0.01 each) and
US$150,000 (in the form of 15,000,000 non-cumulative preference
shares of US$0.01 each),
provided that, unless previously renewed, varied or
revoked by the Company in general meeting, such authority shall
expire at the conclusion of the Annual General Meeting of the
Company to be held in 2023 or at the close of business on 30 June
2023, whichever is the earlier, save that this authority shall
allow the Company before the expiry of this authority to make
offers, and enter into agreements, which would, or might, require
shares to be allotted or rights to subscribe for, or to convert any
security into, shares to be granted after the authority expires and
the Directors may allot shares or grant rights to subscribe for, or
to convert any security into, shares (as the case may be) in
pursuance of such offers or agreements as if the authority
conferred hereby had not expired.
|
This year, the Directors are again seeking authority under section
551 of the Act to allot shares up to an aggregate total nominal
amount of two-thirds of the Company's issued ordinary share capital
subject to the restrictions set out below. The authority given
to the Directors at the 2021 Annual General Meeting will
expire at the conclusion of the 2022 AGM. Resolution 8 will
give the Directors authority to allot new ordinary shares (or
rights to ordinary shares) of up to an aggregate nominal amount of
US$6,737,998,164, representing two-thirds of the Company's issued
ordinary share capital. However, that authority is limited as
follows:
(a)
under paragraph (a) of Resolution 8, up to an aggregate nominal
amount of US$2,021,399,449, representing approximately 20 per cent
of the Company's issued ordinary share capital, may be used for
general allotments;
(b)
under paragraph (b) of Resolution 8, the Directors
would have authority to make allotments which exceed the 20 per
cent authority in paragraph (a) of Resolution 8 in connection with
a pre-emptive offering such as a rights issue, open offer or a
scrip dividend up to an aggregate nominal amount, when combined
with allotments made under paragraph (a), of US$3,368,999,082. This
represents approximately one-third of the issued ordinary share
capital of the Company; and
(c)
under paragraph (c) of Resolution 8, the Directors would have
authority to allot up to an aggregate nominal amount of
US$6,737,998,164 in connection with a rights issue only. This
represents approximately two-thirds of the Company's
issued ordinary share capital. Any allotments or grants under
paragraphs (a) or (b) of Resolution 8 will reduce the level of this
two-thirds authority.
In Resolution 8 paragraph (d), the Board is again seeking authority
to issue sterling, US dollar and euro preference shares without
having first to obtain the consent of shareholders at a general
meeting. These preference shares were created to underpin issues of
preferred securities, which are a tax efficient form of regulatory
capital. If approved by shareholders, this authority will give
Directors the flexibility to raise regulatory capital should
circumstances so require. If any preference shares were to be
issued they would, subject to regulatory approval, be redeemable at
the Company's option and carry no voting rights other than in
exceptional circumstances, but would rank in priority to the
Company's ordinary shares with respect to participation in any
return of capital.
Other than pursuant to the Company's employee share plans, the
Board has no present intention of issuing any further shares
pursuant to the authority in Resolution 8.
If granted, this authority will be effective until the conclusion
of the 2023 Annual General Meeting or the close of business on 30
June 2023, whichever is the earlier.
As at 10 March 2022, being the latest practicable date prior to
printing of this document, the Company held 325,273,407 of its
ordinary shares in treasury, representing 1.58 per cent of the
issued ordinary share capital (including treasury shares) and 1.61
per cent of the issued ordinary share capital (excluding treasury
shares).
|
9. Disapplication of
pre-emption rights#
THAT if Resolution 8 set out in the Notice convening this meeting
is passed, the Directors be authorised to allot equity securities
(as defined in section 560 of the UK Companies Act 2006 (the
"Act")) for cash under the authority given by Resolution 8 and/or
to sell shares held by the Company as treasury shares for cash as
if section 561(1) of the Act did not apply to any such allotment or
sale, such authority to be limited:
(a) to the allotment of equity securities and/or
sale of treasury shares for cash in connection with any rights
issue, or other offer or invitation (but in the case of the
authority granted under paragraph (c) of Resolution 8, by way of a
rights issue only) to:
(i) holders of ordinary shares
in proportion (as nearly as may be practicable) to the respective
number of ordinary shares held by them; and
(ii) holders of other securities,
bonds, debentures or warrants which, in accordance with the rights
attaching thereto, are entitled to participate in such an issue,
offer or invitation or as the Directors consider
necessary,
but in each case
subject to such exclusions or other arrangements as the Directors
may deem necessary or expedient in relation to record dates,
fractional entitlements, treasury shares or securities represented
by depositary receipts or having regard to any restrictions,
obligations, practical or legal problems under the laws of or
the requirements of any
regulatory body or stock exchange in any territory or otherwise
howsoever; and
(b) to the allotment of equity securities and/or sale
of treasury shares (otherwise than under paragraph (a) above) up to
an aggregate nominal amount of US$505,349,862,
provided that, unless previously renewed, varied or revoked by the
Company in general meeting, such authority shall expire at the
conclusion of the Annual General Meeting of the Company to be held
in 2023 or at the close of business on 30 June 2023, whichever is
the earlier, save that this authority shall allow the Company
before expiry of this authority to make offers, and enter into
agreements, which would or might require equity securities to be
allotted (or treasury shares to be sold) after the authority
expires and the Directors may allot equity securities (or sell
treasury shares) under any such offer or agreement as if the
authority had not expired.
|
Resolution 9 is to approve the disapplication of statutory
pre-emption rights under the Act in respect of certain allotments
of shares made under the authorities in Resolution 8. If the
Directors wish to exercise the authority under Resolution 8 and
offer shares (or sell any shares which the Company may purchase or
elect to hold as treasury shares) for cash, the Act requires that
unless shareholders have given specific authority for the
disapplication of their statutory pre-emption rights, the new
shares must be offered first to existing shareholders in proportion
to their existing shareholdings. Resolution 9 seeks to give the
Directors flexibility, in certain circumstances, to allot new
shares (or to grant rights over shares) for cash or to sell
treasury shares for cash without first offering them to existing
shareholders in proportion to their holdings.
Resolution 9 also seeks to give the Directors additional
flexibility in the context of pre-emptive offerings such as a
rights issue, open offer, or scrip dividend, to deal with legal or
practical difficulties in countries outside the UK which prevent
the offer being made on a purely pro rata basis. It also seeks a
disapplication of pre-emption rights in respect of allotments or
sales of treasury shares for cash up to an aggregate nominal amount
of US$505,349,862, representing a further five per cent of the
Company's issued ordinary share capital. This is designed to
reflect the guidelines contained in the Pre-Emption Group's
Statement of Principles on Disapplying Pre-Emption Rights, which
impose a five per cent limit for non-pre-emptive allotments for
cash, excluding certain allotments such as those under employee
share plans.
Other than allotments under employee share plans, the Board has no
present intention of issuing any further ordinary shares pursuant
to the authority in Resolution 9. No issue will be made which would
effectively change the control of the Company or the nature of its
business without the prior approval of shareholders at a general
meeting.
If granted, the authority sought in Resolution 9 will be effective
until the conclusion of the 2023 Annual General Meeting or the
close of business on 30 June 2023, whichever is the
earlier.
In addition, the Company is seeking authority under Resolutions 14
and 15 to allot shares or rights to subscribe for shares in
connection with the issue of Contingent Convertible Securities
("CCSs"), and to disapply statutory pre-emption rights in respect
of such allotment, in each case up to an amount equivalent to
approximately 20 per cent of the Company's issued ordinary share
capital. Assuming Resolutions 14 and 15 are passed, the authority
sought under Resolutions 8, 9 and 10 would not be utilised for the
purpose of the issuance of CCSs. The Company confirms that it
does not intend to issue more than 7.5 per cent of its issued
ordinary share capital (excluding treasury shares) in any rolling
three-year period, without prior consultation with shareholders,
save as permitted in connection with an acquisition or specified
capital investment as described in the notes to Resolution 10.
However, if passed, Resolutions 14 and 15 would permit this level
to be exceeded in connection with the issue of CCSs or the
conversion or exchange of CCSs.
Unless otherwise stated, references in these Explanatory Notes to
the issued ordinary share capital, and to percentages or fractions
of the issued ordinary share capital, are to the issued ordinary
share capital of the Company (calculated exclusive of treasury
shares) as at 10 March 2022, being the latest practicable date
prior to printing this document.
|
10. Further disapplication of
pre-emption rights for acquisitions#
THAT if Resolution 8 set out in the Notice convening this meeting
is passed, the Directors be authorised (in addition to any
authority granted under Resolution 9 set out in the Notice
convening this meeting) to allot equity securities (as defined
in section 560 of the UK Companies Act 2006 (the "Act"))
for cash under the authority given by Resolution 8 and/or
to sell shares held by the Company as treasury shares for cash as
if section 561(1) of the Act did not apply to any such allotment or
sale, such authority to be:
(a) limited to the allotment of equity securities
and/or sale of treasury shares up to a nominal amount of
US$505,349,862; and
(b) used only for the purposes of financing (or
refinancing, if the authority is to be used within six months after
the original transaction) a transaction which the Directors
determine to be an acquisition or other capital investment of a
kind contemplated by the Statement of Principles on Disapplying
Pre-Emption Rights most recently published by the Pre-Emption Group
prior to the date of the Notice convening this
meeting,
provided that, unless previously renewed, varied or revoked by the
Company in general meeting, such authority shall expire at the
conclusion of the Annual General Meeting of the Company to be held
in 2023 or at the close of business on 30 June 2023, whichever is
the earlier, save that this authority shall allow the Company
before expiry of this authority to make offers, and enter into
agreements, which would or might require equity securities to be
allotted (or treasury shares to be sold) after the authority
expires and the Directors may allot equity securities (or sell
treasury shares) under any such offer or agreement as if the
authority had not expired.
|
Resolution 10 is also to approve the disapplication of statutory
pre-emption rights under the Act in respect of certain allotments
of shares made under the authorities in Resolution 8.
Resolution 10 is proposed as a separate resolution to Resolution 9,
in accordance with a recommendation of the Pre-Emption Group and
the guidelines on share capital management issued by the UK's
Investment Association (the "IA Guidelines"), to authorise the
Directors to allot an additional quantity of shares (or sell
treasury shares) for cash otherwise than to existing
shareholders pro rata to their holdings up to an aggregate nominal
amount of US$505,349,862, representing a further five per
cent of the Company's issued share capital. The additional
authority in this Resolution 10 may be used only in connection with
the financing (or refinancing) of an acquisition or specified
capital investment.
In accordance with the Pre-Emption Group's Statement of Principles,
the Directors confirm that they intend to use the authority sought
in Resolution 10 only in connection with such an acquisition or
specified capital investment which is announced contemporaneously
with the issue, or which has taken place in the preceding six month
period and is disclosed in the announcement of the issue, and will
provide shareholders with information regarding the transaction if
the authority is used.
Other than allotments under employee share plans, the Board has no
present intention of issuing any further ordinary shares pursuant
to the authority in Resolution 10. No issue will be made which
would effectively change the control of the Company or the nature
of its business without the prior approval of shareholders at a
general meeting.
If granted, the authority sought in Resolution 10 will be effective
until the conclusion of the 2023 Annual General Meeting or the
close of business on 30 June 2023, whichever is the
earlier.
|
11. Addition of any repurchased shares to general authority
to allot shares*
THAT the authority granted to the Directors to allot shares or
grant rights to subscribe for, or convert any security into, shares
in the Company pursuant to paragraph (a) of Resolution 8 set out in
the Notice convening this meeting be extended by the addition of
such number of ordinary shares of US$0.50 each representing the
nominal amount of the Company's share capital repurchased by the
Company under the authority granted pursuant to Resolutions 12 and
13 set out in the Notice convening this meeting, to the extent that
such extension would not result in any increase in the authority to
allot shares or grant rights to subscribe for, or convert
securities into, shares pursuant to paragraphs (b) and (c) of
Resolution 8 set out in the Notice convening this
meeting.
|
Resolution 11 seeks to extend the Directors' authority to allot
shares and grant rights to subscribe for or convert any security
into shares pursuant to paragraph (a) of Resolution 8 to include
the shares repurchased by the Company under the authority sought by
Resolutions 12 and 13. This is permitted by the Hong Kong Listing
Rules.
|
12. Purchases of Ordinary Shares
by the Company#
THAT the Company be and is hereby generally and unconditionally
authorised for the purposes of section 701 of the UK Companies Act
2006 (the "Act") to make market purchases (within the meaning of
section 693(4) of the Act) of Ordinary Shares of US$0.50 each
("Ordinary Shares") and on such terms and in such manner as the
Directors shall from time to time determine provided
that:
(a) the maximum aggregate number of Ordinary
Shares hereby authorised to be purchased is 2,021,399,449 Ordinary
Shares, such limit to be reduced by the number of Ordinary Shares
purchased from time to time pursuant to the authority granted by
Resolution 13;
(b) he minimum price (exclusive of expenses)
which may be paid for each Ordinary Share is US$0.50 or the
equivalent in the relevant currency in which the purchase is
effected calculated by reference to the spot rate of exchange for
the purchase of United States dollars with such other currency as
quoted by HSBC Bank plc in the London Foreign Exchange Market at or
about 11.00am London time on the business day (being a day on which
banks are ordinarily open for the transaction of normal banking
business in London) prior to the date on which the Ordinary Share
is contracted to be purchased, in each case such rate to be the
rate as conclusively certified by an officer of HSBC Bank
plc;
(c) the maximum price (exclusive of expenses) which may
be paid for each Ordinary Share is the lower of (i) 105 per cent of
the average of the middle market quotations for the Ordinary Shares
(as derived from the Daily Official List of the London Stock
Exchange plc) for the five dealing days immediately preceding the
day on which the Ordinary Share is contracted to be purchased, or
(ii) 105 per cent of the average of the closing prices of the
Ordinary Shares on The Stock Exchange of Hong Kong Limited for the
five dealing days immediately preceding the day on which the
Ordinary Share is contracted to be purchased, in each case
converted (where relevant) into the relevant currency in which the
purchase is effected calculated by reference to the spot rate of
exchange for the purchase of such currency with the currency in
which the quotation and/or price is given as quoted by HSBC Bank
plc in the London Foreign Exchange Market at or about 11.00am
London time on the business day prior to the date on which the
Ordinary Share is contracted to be purchased, in each case such
rate to be the rate as conclusively certified by an officer of HSBC
Bank plc;
(d) unless previously renewed, revoked or varied by the
Company in general meeting, this authority shall expire at the
conclusion of the Annual General Meeting of the Company to be held
in 2023 or at the close of business on 30 June 2023, whichever is
the earlier; and
(e) the Company may prior to the expiry of this
authority make a contract or contracts to purchase Ordinary Shares
under this authority which will or may be completed or executed
wholly or partly after such expiry and may make a purchase of
Ordinary Shares pursuant to any such contract or contracts as if
the authority conferred hereby had not expired.
|
The purpose of the authority to be conferred by this resolution is
to enable the Company to make market purchases of its own shares.
The maximum and minimum prices at which they may be bought,
exclusive of expenses, are specified in the
resolution.
These notes should be read together with the notes to Resolution 13
which relate to the ability of the Company to make off-market
purchases (within the meaning of section 693(2) of the Act) of its
own shares.
The Directors consider that it is appropriate to seek authority for
the Company to make purchases under Resolutions 12 and 13 which
together represent up to 10 per cent of its own Ordinary Shares.
Any repurchases under the authority in Resolution 13 will reduce
the available authority under this Resolution 12 and vice versa.
The Company will consider share buy-backs in periods where we have
an excess capital position absent compelling investment
opportunities to deploy that excess. It remains the Directors'
policy to maintain a strong capital base, a policy which has
consistently been one of the Group's strengths. As the Group
executes its strategy, the appropriate level of capital to be held
will be continually reviewed. Having these authorities will give
Directors the flexibility, if they consider it in the interests of
the Company and shareholders, to purchase Ordinary Shares in
appropriate circumstances, for example, in the event that the
Company is unable to deploy the retained capital to create
incremental value for shareholders, subject to regulatory approval.
The Company may decide to retain any shares it purchases as
treasury shares with a view to a possible re-issue at a later date,
transfer in connection with an employee scheme, or it may cancel
the shares. The current intention is that all shares repurchased
pursuant to Resolution 12 will be cancelled.
On 26 October 2021, the Company commenced a share buy-back to
purchase its Ordinary Shares up to a maximum consideration of
U$2bn. This programme will end no later than 20 April 2022.
Ordinary Shares repurchased to date pursuant to this programme have
been cancelled. In addition, the Company announced on 22 February
2022 the intention to initiate a further buy-back of up to US$1bn,
to commence after the existing buy-back has concluded.
Under section 693 of the Act, the Company is only permitted to make
market purchases of its Ordinary Shares on a recognised investment
exchange. Of the venues where the Company's Ordinary Shares are
listed, only the London Stock Exchange is currently designated as a
recognised investment exchange.
If Resolution 12 is passed, the authority will be effective until
the conclusion of the 2023 Annual General Meeting or the close of
business on 30 June 2023, whichever is earlier.
Notes which apply to Resolutions 12 and 13
The Act permits the Company to elect to hold in treasury any
Ordinary Shares it may repurchase, rather than automatically
cancelling those shares. Approval has been received from the
relevant regulatory authorities in Hong Kong to enable the Company
to hold repurchased shares in treasury. The conditional waiver
granted by The Stock Exchange of Hong Kong Limited (the "Hong Kong
Stock Exchange") on 19 December 2005 was granted on the basis of
certain agreed modifications to the Rules Governing the Listing of
Securities on The Stock Exchange of Hong Kong Limited ("Hong Kong
Listing Rules") applicable to the Company. Details of the
modifications are available at www.hsbc.com and the Hong Kong Stock
Exchange's HKEX news website at www.hkexnews.hk. Copies of the
modifications are also available from the Group Company Secretary
and Chief Governance Officer, HSBC Holdings plc, 8 Canada Square,
London E14 5HQ, United Kingdom and the Corporation Secretary and
Regional Company Secretary Asia-Pacific, The Hongkong and Shanghai
Banking Corporation Limited, 1 Queen's Road Central, Hong Kong
SAR.
Further details regarding the proposed authority to be given to the
Company to purchase its own shares and the waiver granted by the
Hong Kong Stock Exchange are set out in Appendix 2.
The total number of options to subscribe for Ordinary Shares
outstanding on 10 March 2022, being the latest practicable
date prior to printing of this document, was 119,898,415 which
represented 0.59 per cent of the issued ordinary share capital
(excluding treasury shares) as at that date. If the Company were to
purchase the maximum number of Ordinary Shares permitted by
this Resolution 12 and Resolution 13, the options
outstanding on 10 March 2022 would represent 0.66 per cent of
the issued ordinary share capital (excluding treasury shares) as at
10 March 2022.
|
13. Approval of form of share
repurchase contract#
THAT the terms of a share repurchase contract (in the form produced
to the meeting and initialled by the Chairman for the purposes of
identification) (the "Contract") providing for off-market purchases
(within the meaning of section 693(2) of the UK Companies Act 2006)
by the Company of its ordinary shares of US$0.50 each ("Ordinary
Shares") pursuant to such Contract be and are hereby approved and
the Company be and is hereby authorised to enter into and complete
one or more Contracts between the Company and any or all of Merrill
Lynch International and Morgan Stanley & Co. International plc,
provided that:
(a) the maximum aggregate number of Ordinary
Shares hereby authorised to be purchased is 2,021,399,449 Ordinary
Shares, such limit to be reduced by the number of Ordinary Shares
purchased from time to time pursuant to the authority granted by
Resolution 12;
(b) the minimum price (exclusive of expenses) which may
be paid for each Ordinary Share is US$0.50 or the equivalent in the
relevant currency in which the purchase is effected calculated by
reference to the spot rate of exchange for the purchase of United
States dollars with such other currency as quoted by HSBC Bank plc
in the London Foreign Exchange Market at or about 11.00am London
time on the business day (being a day on which banks are ordinarily
open for the transaction of normal banking business in London)
prior to the date on which the Ordinary Share is contracted to be
purchased, in each case such rate to be the rate as conclusively
certified by an officer of HSBC Bank plc;
(c) the maximum price (exclusive of expenses) which may
be paid for each Ordinary Share is the lower of (i) 105 per cent of
the average of the middle market quotations for the Ordinary Shares
(as derived from the Daily Official List of the London Stock
Exchange plc) for the five dealing days immediately preceding the
day on which the Ordinary Share is contracted to be purchased, or
(ii) 105 per cent of the average of the closing prices of the
Ordinary Shares on The Stock Exchange of Hong Kong Limited for the
five dealing days immediately preceding the day on which the
Ordinary Share is contracted to be purchased, in each case
converted (where relevant) into the relevant currency in which the
purchase is effected calculated by reference to the spot rate of
exchange for the purchase of such currency with the currency in
which the quotation and/or price is given as quoted by HSBC Bank
plc in the London Foreign Exchange Market at or about 11.00am
London time on the business day prior to the date on which the
Ordinary Share is contracted to be purchased, in each case such
rate to be the rate as conclusively certified by an officer of HSBC
Bank plc;
(d) unless previously renewed, revoked or varied by the
Company in general meeting, this authority shall expire at the
conclusion of the Annual General Meeting of the Company to be held
in 2023 or at the close of business on 30 June 2023, whichever is
the earlier; and
(e) the Company may purchase Ordinary Shares under this
authority which will or may be completed or executed wholly or
partly after the expiry of the authority as if the authority
conferred hereby had not expired.
|
As mentioned in the notes to Resolution 12, market purchases of a
company's own shares may only be made on a recognised investment
exchange. The Hong Kong Stock Exchange is not currently a
recognised investment exchange. Therefore, in order to undertake
share buybacks on the Hong Kong Stock Exchange as well as in the
UK, the Company needs to comply with specific procedures under the
Act for "off market" purchases of shares. The Hong Kong Buybacks
(as defined below) will be an "On-market share buy-back" under the
Hong Kong Listing Rules and the Hong Kong Codes on Takeovers and
Mergers and Share Buy-backs and will comply with the requirements
of Rule 10.06 of the Hong Kong Listing Rules (save to extent set
out below).
In order for the Company to carry out repurchases on the Hong Kong
Stock Exchange ("Hong Kong Buybacks") within the legal framework of
the Act, the Company proposes to approve a form of repurchase
contract (the "Contract") and the appointment of Merrill Lynch
International and/or Morgan Stanley & Co. International plc
(each a "Broker") under one or more Contracts which will provide
that:
(a)
the Broker will buy Ordinary Shares on the Hong Kong Stock Exchange
on a principal basis; and
(b)
the Broker will be contractually bound to on-sell all of the
Ordinary Shares bought on the Hong Kong Stock Exchange to the
Company at the same price at which the Broker purchased the
Ordinary Shares.
The intention is for the Company to be able to carry out share
buybacks in the UK and Hong Kong. Any such buybacks could be
carried out in the UK and Hong Kong in parallel or separately.
Previously, the Company has only carried out buybacks in the UK
pursuant to the equivalent of the on-market repurchase authority in
Resolution 12.
Under any Contract, the relevant Broker will be appointed on an
irrevocable, non-discretionary basis for a specified period to buy
Ordinary Shares within certain parameters set out in the Schedule
to the Contract. Subject to these parameters, decisions on when to
buy or how much to pay for the Ordinary Shares will be made by the
Broker independently of the Company.
The appointment of the Broker to manage the buyback programme and
take decisions independently of the Company is to ensure that the
share buyback fits within the parameters of the safe harbour in
article 4 of the regulatory technical standards contained in
Commission Delegated Regulation EU 2016/1052 as it applies in the
UK (the "UK Buyback Safe Harbour"). The arrangements include the
Broker taking the decision to buy the shares (with information
barriers in place to ensure that the team at the Broker making the
purchases does not have access to inside information or unpublished
financial information of the Company) and the Company being under a
pre-existing obligation to purchase whatever shares the Broker buys
at the same price. This allows the buyback to continue during the
Company's closed periods prior to the announcement of its financial
results and during periods when it has inside information. However,
the Company would only enter into the Contract when it was outside
a closed period and at a time when it was not in possession of
inside information. As well as to fit within the parameters of the
UK Buyback Safe Harbour (and equivalent safe harbours under the
rules in the United States), this structure also ensures compliance
with the Rule 10.06(2)(e) Waiver (as defined below) granted by the
Hong Kong Stock Exchange which is described in further detail
below.
The buying parameters set out in the Schedule to the Contract place
certain restrictions on the price that the Broker may pay and the
volume and speed with which it can make purchases. These
restrictions are in place to comply with the UK Buyback Safe
Harbour, equivalent safe harbours under the rules in the United
States, the limits in Resolutions 12 and 13, the UK Listing Rules
and Hong Kong Listing Rules. These include restrictions to ensure
that purchases on any day do not exceed 25% of the average daily
trading volume for that venue, that the price paid on any venue is
not higher than the last independent trade and the highest current
independent bid on that venue, and that no purchases will be made
as the opening transaction on a venue or in the last 10 minutes
before the scheduled close of the primary trading session on that
venue.
These arrangements are the same as those adopted by the Company for
its previous on-market buybacks in the UK.
On 31 December 2021, the Hong Kong Stock Exchange granted to the
Company a waiver from strict compliance with Rule 10.06(2)(e) of
the Hong Kong Listing Rules to enable it to conduct the Hong Kong
Buybacks during the Company's closed periods and when it is in
possession of inside information provided that the Broker is
appointed on an irrevocable non-discretionary basis during these
periods ("Rule 10.06(2)(e) Waiver") and that the Hong Kong Buy-Back
is subject to the purchase restrictions summarised
above.
Approval of the form of the Contract and counterparties is not an
approval of a specific share buyback activity or the amount or
timing of any repurchase activity. Ordinary Shares will be
repurchased by the Company in accordance with a specific share
buyback activity or share buyback programme if it is approved by
the Board. There can be no assurance as to whether a Hong Kong
Buyback will be used to repurchase any of the Ordinary Shares or,
if a Hong Kong Buyback is used, the amount of any such buyback or
the prices at which such buyback may be made. However, the maximum
and minimum prices at which any buyback may be made, exclusive of
expenses, are specified in the resolution.
As mentioned in the notes to Resolution 12, the Company will
consider share buy-backs in periods where we have an excess capital
position absent compelling investment opportunities to deploy that
excess. It remains the Directors' policy to maintain a strong
capital base, a policy which has consistently been one of the
Group's strengths. As the Group executes its strategy, the
appropriate level of capital to be held will be continually
reviewed. Having these authorities will give Directors the
flexibility, if they consider it in the interests of the Company
and shareholders, to purchase Ordinary Shares in appropriate
circumstances, for example, in the event that the Company is unable
to deploy the retained capital to create incremental value for
shareholders, subject to regulatory approval. The Contract provides
for any share repurchased under the Contract to be
cancelled.
The Directors consider that it is appropriate to seek authority for
the Company to make purchases under Resolutions 12 and 13 which
together represent up to 10 per cent of its own Ordinary
Shares.
The Directors' intention is only to use the authority under this
resolution to carry out Hong Kong Buybacks. If the Directors
decided to exercise the authority given to them under this
resolution, it may be exercised in conjunction with any repurchases
under Resolution 12 or separately. Any repurchases under the
authority in Resolution 12 will reduce the available authority
under this Resolution 13 and vice versa.
The disclosures contained in the notes to Resolution 12 under the
heading "Notes which apply to Resolutions 12 and 13" apply equally
to this Resolution.
Copies of the Contract and the list of proposed counterparties to
such Contract will be made available for shareholders to inspect at
the Company's registered office at 8 Canada Square, London E14 5HQ,
United Kingdom from 25 March 2022 until the date of the AGM. Copies
of the Contract and the list of repurchase counterparties will also
be available for inspection at the AGM.
If Resolution 13 is passed, the authority will be effective and the
Company may repurchase shares pursuant to the form of Contract
with the relevant counterparties until the conclusion of the 2023
Annual General Meeting or the close of business on 30 June 2023,
whichever is earlier.
|
14. Additional authority to allot equity securities in
relation to the issue of Contingent Convertible
Securities*
THAT in addition to any authority granted pursuant to Resolution 8
set out in the Notice convening this meeting, the Directors be
generally and unconditionally authorised under and for the purposes
of section 551 of the UK Companies Act 2006 (the "Act") to exercise
all the powers of the Company to allot shares in the Company and to
grant rights to subscribe for, or to convert any security into,
shares in the Company up to an aggregate nominal amount of
US$2,021,399,449 in relation to any issue by the Company or any
member of the Group of Contingent Convertible Securities ("CCSs")
that automatically convert into or are exchanged for ordinary
shares in the Company in prescribed circumstances where the
Directors consider such an issue of CCSs would be desirable in
connection with, or for the purposes of, complying with or
maintaining compliance with regulatory capital requirements or
targets applicable to the Group from time to time and otherwise on
terms as may be determined by the Directors, provided that, unless
previously renewed, varied or revoked by the Company in general
meeting, such authority shall expire at the conclusion of the
Annual General Meeting of the Company to be held in 2023 or at the
close of business on 30 June 2023, whichever is the earlier, save
that this authority shall allow the Company before the expiry of
this authority to make offers, and enter into agreements, which
would or might require shares to be allotted or rights to subscribe
for, or to convert any security into, shares to be granted after
the authority expires and the Directors may allot shares or grant
rights to subscribe for, or to convert any security into, shares
(as the case may be) in pursuance of such offers or agreements as
if the authority conferred hereby had not expired.
|
Resolution 14 is to give the Directors the authority to
allot shares and grant rights to subscribe for, or to convert,
any security into ordinary shares in the Company up to an aggregate
nominal amount of US$2,021,399,449 equivalent to approximately 20
per cent of the ordinary shares in issue on 10 March 2022, being
the latest practicable date prior to printing this document. This
authority relates to the issue of CCSs.
This should be read together with the notes to Resolution 15 which
relate to the ability of the Company to allot CCSs, or shares
issued upon conversion or exchange of CCSs, without the need to
first offer them to existing shareholders.
CCSs are debt securities which benefit from a specific regulatory
capital treatment under European Union and United Kingdom
legislation. They are treated as Additional Tier 1 Capital and, as
a banking group, HSBC is able to hold a certain amount of its Tier
1 Capital in the form of Additional Tier 1 Capital. The CCSs will
be converted or exchanged into ordinary shares if a defined trigger
event occurs (which currently is the HSBC Group's Common Equity
Tier 1 Capital ratio falling below 7 per cent). Issuing CCSs gives
the Company greater flexibility to manage its capital in the most
efficient and economic way for the benefit of the shareholders.
Please see Appendix 1 for more information on CCSs.
This authority is in addition to the authority proposed in
Resolutions 8, 9 and 10, which contain the general authority sought
on an annual basis in line with IA Guidelines and the Hong Kong
Listing Rules.
If Resolutions 14 and 15 are passed, the Company will only issue
CCSs pursuant to the authority granted under these resolutions and
not under the authority granted under Resolutions 8, 9 and 10.
Although the authority in Resolutions 14 and 15 is not contemplated
by the IA Guidelines, it has previously been discussed with the
Investment Association with no-objection.
The authorities in Resolutions 14 and 15 will be utilised as
considered desirable to comply with or maintain compliance with the
regulatory capital requirements arising in connection with the
relevant European Union and United Kingdom legislation and the
prudential regulatory requirements imposed by the Prudential
Regulation Authority ("PRA") and only for those purposes. The
Company will not utilise the authority in Resolutions 14 and 15 to
issue new securities for any other purposes. However, pursuant to
the authority under Resolutions 14 and 15, the Company may issue
additional securities in order to manage the redemption of
outstanding CCSs.
The authority in Resolution 14 would be effective until the
conclusion of the Company's 2023 Annual General Meeting or the
close of business on 30 June 2023, whichever is the earlier. The
Directors expect to seek similar authorities on an annual
basis.
|
15. Limited disapplication of
pre-emption rights in relation to the issue of Contingent
Convertible Securities#
THAT if Resolution 14 set out in the Notice convening this meeting
is passed, the Directors be authorised (in addition to any
authority granted under Resolutions 9 and 10 set out in the Notice
convening this meeting) to allot equity securities (as defined in
section 560 of the UK Companies Act 2006 (the "Act")) for cash
under the authority given by Resolution 14 and/or to sell shares
held by the Company as treasury shares for cash as if section
561(1) of the Act did not apply to any such allotment or sale,
provided that, unless previously renewed, varied or revoked by the
Company in general meeting, such authority shall expire at the
conclusion of the Annual General Meeting of the Company to be held
in 2023 or at the close of business on 30 June 2023, whichever is
the earlier, save that this authority shall allow the Company
before expiry of this authority to make offers, and enter into
agreements, which would or might require equity securities to be
allotted (or treasury shares to be sold) after the authority
expires and the Directors may allot equity securities (or sell
treasury shares) under any such offer or agreement as if the
authority had not expired.
|
The effect of Resolution 15 is to give the Directors' authority to
allot CCSs, or shares issued upon conversion or exchange of CCSs,
without the need to first offer them to existing shareholders. If
passed, Resolution 15 will authorise the Directors to allot shares
and grant rights to subscribe for, or to convert any security into,
shares in the Company (or to sell treasury shares held by the
Company following any purchase of its own shares) on a
non-pre-emptive basis up to an aggregate nominal amount of
US$2,021,399,449, representing approximately 20 per cent of the
ordinary shares in issue on 10 March 2022 such authority to be
exercised in connection with the issue of CCSs.
As at 10 March 2022, being the latest practicable date prior to
printing of this document, the Company held 325,273,407 of its
ordinary shares in treasury, representing 1.58 per cent of the
issued ordinary share capital (including treasury shares) and 1.61
per cent of the issued ordinary share capital (excluding treasury
shares).
As mentioned in the notes to Resolution 14, the authorities in
Resolutions 14 and 15 will be utilised as considered desirable to
comply with or maintain compliance with the regulatory capital
requirements arising in connection with the relevant European Union
and United Kingdom legislation and the prudential regulatory
requirements imposed by the PRA and only for those purposes. The
Company will not utilise the authority in Resolutions 14 and 15 to
issue new securities for any other purposes. However, pursuant to
the authority under Resolutions 14 and 15, the Company may issue
additional securities in order to manage the redemption of
outstanding CCSs.
The authority in Resolution 15 would be effective until the
conclusion of the Company's 2023 Annual General Meeting or the
close of business on 30 June 2023, whichever is the earlier. The
Directors expect to seek similar authorities on an annual
basis.
|
16. Renewal of scrip dividend authority*
THAT the Directors be and are hereby empowered to exercise the
powers conferred upon them by Article 155.1 of the Articles of
Association of the Company, or if Resolution 17(a) set out in the
Notice convening this meeting is passed, Article 153.1 of the
Articles of Association of the Company (as from time to time
varied) so that, to the extent and in the manner determined by the
Directors, the holders of Ordinary Shares of US$0.50 each
("Ordinary Shares") be permitted to elect to receive Ordinary
Shares instead of all or part of any dividend (including interim
dividends) declared or paid up to the conclusion of the Annual
General Meeting of the Company to be held in 2025 to the extent
that the Directors decide, at their discretion, to offer a scrip
dividend alternative in respect of such dividend.
|
As announced on 23 February 2021, HSBC decided to discontinue its
scrip dividend alternative and pay dividends entirely in cash.
However, the Directors wish to retain the flexibility to
reintroduce the scrip dividend alternative in future if the
Directors consider it appropriate or desirable to do
so.
The authority for the Directors to offer a scrip dividend
alternative, whereby shareholders may elect to receive ordinary
shares instead of dividends in cash was last renewed at the 2019
AGM. Under the IA Guidelines, shareholder approval to renew the
authority for the Directors to offer a scrip dividend alternative
may be sought for up to three years.
Resolution 16 gives the Directors authority to offer a scrip
dividend alternative for a further three years expiring on the
conclusion of the AGM in 2025 to satisfy elections for scrip
dividends with ordinary shares (whether new ordinary shares
credited as fully paid or treasury shares). Unless circumstances
change, we would expect to seek an extension of this authority at
the AGM of the Company to be held in 2025.
|
17. Amendments to Articles of
Association#
As separate special resolutions:
(a) THAT, with effect from the conclusion of the
Annual General Meeting, the Articles of Association produced to the
meeting, and initialled for the purpose of identification by the
Chairman, be and are hereby adopted as the Articles of Association
of the Company, in substitution for, and to the exclusion of, the
current Articles of Association.
(b) THAT, subject to the passing of Resolution
17(a) set out in the Notice convening this meeting and conditional
on and with effect from the adoption of the new Articles of
Association (the "New Articles") as proposed in Resolution 17(a)
becoming effective, the New Articles be amended by the adoption and
inclusion of a new Article 171, in the form set out in Appendix 4
of the Notice convening this meeting, immediately following the
existing Article 170 in the New Articles.
|
Resolution 17(a) proposes the adoption of new Articles of
Association of the Company (the "New Articles") in place of the
Company's current Articles of Association which were adopted at the
2018 AGM (the "Current Articles") with effect from the conclusion
of the meeting. The changes being introduced in the New Articles
are summarised in Appendix 3 on pages 24 and 25 and are primarily
to reflect developments in market practice since the Current
Articles were last amended and to provide clarification and
additional flexibility where necessary or appropriate.
Subject to Resolution 17(a) being passed, Resolution 17(b), which
will be proposed as a separate special resolution, proposes the
inclusion of a new Article 171 as set out in Appendix 4 on page 25.
This Article makes it clear that certain claims involving the
Company, its subsidiaries and/ or its or their current or former
directors, officers and employees should be determined in the
English or Hong Kong courts. Further details can be found in
Appendix 3 on page 25 under the heading "Dispute resolution". If
Resolution 17(a) is passed but Resolution 17(b) is not passed, then
Article 171 will not be included in the New Articles.
|
18. Notice of general
meetings#
THAT the Directors be authorised to call general meetings (other
than annual general meetings) on a minimum of 14 clear days'
notice.
|
The Act provides that the minimum notice period for general
meetings of the Company is 21 days unless shareholders approve a
shorter notice period. The passing of this resolution would enable
the Company to call general meetings (other than annual general
meetings) on a minimum of 14 clear days' notice. This shorter
notice period of between 14 and 20 days would not be used as a
matter of routine, but only when the Directors determine that
calling a meeting on less than 21 days' notice is merited by the
business of the meeting and consider it to be to the advantage of
shareholders as a whole. The approval would be effective until the
conclusion of the Company's 2023 Annual General Meeting or the
close of business on 30 June 2023, whichever is the earlier, when
it is intended that a similar resolution will be
proposed.
|
19. Shareholder requisitioned
resolution - Midland Clawback Campaign#
Following shareholder rejection of special resolutions relating to
clawback at the last 3 AGM's, and the Bank's unwillingness to
discuss this matter face to face, the campaign has commissioned and
set aside funds and launched a new crowdfunding appeal to pay for
two law schools to undertake independent academic research of how
"State Deduction" is applied to the post 1975 members of the
Midland Bank scheme.
This resolution simply requests shareholders to instruct the bank
to co-operate with the researchers, and using the findings,
irrespective of outcome, as a basis for the bank and campaign group
to discuss and resolve any unequal treatment
identified.
(More details of the research being undertaken are given in the
explanatory statement that accompany this resolution)
|
Resolution 19 is a special resolution that has not been proposed by
your Board but has been requisitioned by a group of shareholders
for the Midland Clawback Campaign. Resolution 19 has been supplied
to HSBC by a representative of the shareholder group proposing
Resolution 19 and it should be read together with their explanatory
statement in support of the proposed resolution set out in Appendix
5 on page 26.
Your Board's response, which sets out why the Directors unanimously
recommend that you vote AGAINST Resolution 19, is provided in
Appendix 6 on pages 26 to 28. Your Board considers that Resolution
19 is not in the best interests of the Company and its shareholders
as a whole and unanimously recommends that you vote AGAINST
Resolution 19.
By order of the Board
Aileen Taylor
Group Company Secretary and Chief Governance Officer
25 March 2022
HSBC Holdings plc
Incorporated in England with limited liability.
Registered in England: number 617987
Registered Office and Group Head Office:
8 Canada Square, London E14 5HQ, United Kingdom
* Ordinary Resolution
# Special Resolution
Information about the 2022 Annual General Meeting
Venue
The AGM will be held at the Queen Elizabeth Hall, Southbank Centre,
Belvedere Road, London, SE1 8XX and can easily be reached by public
transport. A location map is below.
Shareholders should check the latest UK Government guidelines on
Covid-19 restrictions at the time of the AGM. Shareholders should
also monitor the Company's website at www.hsbc.com/agm, as well as
our stock exchange announcements, for the latest information on any
restrictions or additional procedures that will be in place at the
AGM or any changes to the current arrangements.
Shareholders wishing to attend the AGM electronically should follow
the instructions set out on pages 19 to 20 and in Appendix
8.
Access
The Queen Elizabeth Hall is accessible by wheelchair. The
auditorium is fitted with an induction loop.
To help us ensure that the AGM is fully accessible to all
shareholders, please contact Corporate Governance & Secretariat
at shareholderquestions@hsbc.com if you have any
particular access requirements or other needs.
Security
Security checks will be carried out on entry to the AGM.
Shareholders are reminded that cameras and recording equipment will
not be allowed and all mobile telephones must be switched off or
set to silent. Shareholders are encouraged to leave coats and bags
in the cloakroom provided.
To ensure optimum security within the auditorium, please note that
you will be provided with a wristband once you have been through
the security checks at the venue. You must show your wristband to
gain entry to the AGM.
Entitlement to attend and vote
Pursuant to the Uncertificated Securities Regulations 2001 (as
amended), changes to entries on the principal register of members
of the Company maintained in England (the "Principal Register") or
either the Hong Kong or Bermuda Overseas Branch Registers of the
Company (the "Branch Registers"), as appropriate, after 12.01am
London time (7.01am Hong Kong time) on Thursday, 28 April 2022
or 12.01am London time (7.01am Hong Kong time) on the day
immediately before the day of any adjourned meeting (as the case
may be) shall be disregarded in determining the rights of a
shareholder to attend or vote at the AGM or any adjourned meeting
(as the case may be). Accordingly, a shareholder entered on the
Principal Register or the Branch Registers at 12.01am London time
(7.01am Hong Kong time) on Thursday, 28 April 2022 or 12.01am
London time (7.01am Hong Kong time) on the day immediately before
the day of any adjourned meeting (as the case may be) shall be
entitled to attend and vote at the AGM or any adjourned meeting (as
the case may be) in respect of the number of such shares entered
against the shareholder's name at that time.
Voting
Voting at the AGM will be conducted by way of a poll. This means
that each shareholder present or represented (in person or
electronically) will be able to exercise one vote for each share
held. In the case of joint registered holders of any share, the
vote of the senior who tenders a vote, whether in person,
electronically or by proxy, shall be accepted to the exclusion of
the votes of the other joint holder(s). For this purpose, seniority
shall be determined by the order in which the names of the holders
stand in the Principal Register or the Branch Registers of the
Company, as appropriate.
Shareholders will be able to vote by either submitting a proxy in
advance of the AGM or by voting on the day of the AGM either in
person at the meeting or via the Lumi website following the
instructions set out on pages 19 to 20 and in Appendix 8 for those
shareholders attending the AGM electronically.
Shareholders are strongly encouraged to appoint the Chairman of the
AGM as their proxy, even if they intend to attend the AGM in person
or electronically. This is to ensure that your vote is counted if
you are unable to attend on the day of the AGM.
The completion and submission of a form of proxy will not preclude
you from attending and voting in person or electronically at the
AGM. Information on how to appoint a proxy is set out
below.
Shareholders who attend the AGM electronically will be able to vote
on all the resolutions put to the AGM. Instructions on how
shareholders can exercise their votes whilst attending the AGM
electronically are set out below.
Following the conclusion of the AGM, voting results will be
published on the Company's website at
www.hsbc.com/agm.
Appointing a proxy
Shareholders are strongly encouraged to vote on the resolutions in
advance of the AGM by completing a proxy form appointing the
Chairman of the AGM as your proxy. You may appoint the Chairman of
the AGM or a person of your choice to be your proxy to attend,
speak and vote on your behalf. A proxy need not be a member of the
Company. You may appoint more than one proxy, provided that each
proxy is appointed to exercise the rights attached to a different
share or shares held by you. If you require additional forms of
proxy, you may photocopy the original form of proxy enclosed or ask
our registrar to send you additional forms (see "How to submit your
form of proxy" below for the registrar's address).
As explained above under "Voting", shareholders are strongly
encouraged to appoint the Chairman of the AGM as their proxy, even
if they intend to attend the AGM in person or electronically. This
is to ensure that your vote is counted if you are unable to attend
on the day.
If you appoint a proxy, other than the Chairman of the AGM, and
they wish to attend the meeting electronically, they will need to
contact the Company's registrar before 11.00am London time (6.00pm
Hong Kong time) on Wednesday, 27 April 2022 to arrange for the
necessary details to be sent to them. See further details set out
on pages 19 to 20.
A form of proxy is enclosed with this document or may be accessed
at www.hsbc.com/proxy.
How to submit your form of proxy
The form of proxy must be received by 11.00am London time (6.00pm
Hong Kong time) on Wednesday, 27 April 2022, or not less than 48
hours before the time of the holding of any adjourned
meeting.
You may submit your form of proxy electronically at
www.hsbc.com/proxy by entering your Shareholder Reference
Number and the Personal Identification Number which is either
printed on your form of proxy or which has been sent to you by
email if you have registered an email address to receive electronic
communications.
Alternatively, you may send your completed form of proxy
to:
− Computershare Investor Services PLC, The
Pavilions, Bridgwater Road, Bristol, BS99 6ZY, United
Kingdom;
− Computershare Hong Kong Investor Services Limited,
Rooms 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road
East, Hong Kong SAR; or
− Investor Relations Team, HSBC Bank Bermuda
Limited, 37 Front Street, Hamilton HM 11,
Bermuda.
For shares held through CREST, proxy appointments may be submitted
via the CREST proxy voting system (see section on "CREST" set out
below).
In order to be valid, the completed form of proxy (together with
any power of attorney or other authority under which it is signed,
or a copy of such authority certified notarially or in some other
way approved by the Board) must be deposited by 11.00am London time
(6.00pm Hong Kong time) on Wednesday, 27 April 2022, or not less
than 48 hours before the time of the holding of any adjourned
meeting, at the offices of the Company's registrar (see above for
the registrar's address). Any power of attorney or other authority
relating to an appointment of a proxy cannot be submitted
electronically and must be deposited as referred to above for the
appointment to be valid.
CREST
CREST members who wish to appoint a proxy or proxies by using the
CREST electronic proxy appointment service may do so for the AGM or
any adjourned meeting by following the procedures described in the
CREST manual. CREST personal members or other CREST sponsored
members, and those CREST members who have appointed a voting
service provider, should refer to their CREST sponsor or voting
service provider, who will be able to take the appropriate action
on their behalf.
In order for a proxy appointment or instruction made by means of
CREST to be valid, the appropriate CREST message (a "CREST Proxy
Instruction") must be properly authenticated in accordance with
Euroclear UK & International Limited's specifications and must
contain the information required for such instructions, as
described in the CREST manual. The message, regardless of whether
it constitutes the appointment of a proxy or is an amendment to the
instruction given to a previously appointed proxy, must, in order
to be valid, be transmitted so as to be received by the issuer's
agent (ID 3RA50) by 11.00am London time (6.00pm Hong Kong time) on
Wednesday, 27 April 2022, or not less than 48 hours before the time
of the holding of any adjourned meeting. For this purpose, the time
of receipt will be taken to be the time (as determined by the
timestamp applied to the message by the CREST Applications Host)
from which the issuer's agent is able to retrieve the message by
enquiry to CREST in the manner prescribed by CREST. After this
time, any change of instructions to proxies appointed through CREST
should be communicated to the appointees through other
means.
CREST members, and, where applicable, their CREST sponsor or voting
service providers should note that Euroclear UK & International
Limited does not make available special procedures in CREST for any
particular messages. Normal system timings and limitations will
therefore apply in relation to the input of CREST Proxy
Instructions. It is the responsibility of the CREST member
concerned to take (or, if the CREST member is a CREST personal
member or sponsored member or has appointed a voting service
provider, to procure that their CREST sponsor or voting service
provider takes) such action as shall be necessary to ensure that a
message is transmitted by means of the CREST system by any
particular time. In this connection, CREST members and, where
applicable, their CREST sponsors or voting service providers are
referred, in particular, to those sections of the CREST manual
concerning practical limitations of the CREST system and
timings.
Pursuant to Regulation 35(5)(a) of the Uncertificated Securities
Regulations 2001 (as amended) the Company may treat as invalid a
CREST Proxy Instruction if the Company has actual notice
that:
− information in the instruction is
incorrect;
− the person expressed to have sent the instruction
did not in fact send it; or
− the person sending the instruction on behalf of
the relevant shareholder did not have the authority to do
so.
Nominated persons
The right to appoint a proxy does not apply to persons whose shares
are held on their behalf by another person who has been nominated
to receive communications from the Company in accordance with
section 146 of the UK Companies Act 2006 (the "Act") ("nominated
persons"). Nominated persons may have a right under an agreement
with the registered shareholder who holds the shares on their
behalf to be appointed (or to have someone else appointed) as a
proxy for the AGM. Alternatively, if nominated persons do not have
such a right, or do not wish to exercise it, they may have a right
under such an agreement to give instructions to the person holding
the shares as to the exercise of voting rights at the
AGM.
The main point of contact for nominated persons remains the
registered shareholder (for example the stockbroker, investment
manager, custodian or other person who manages the investment). Any
changes or queries relating to nominated persons' personal details
and holdings (including any administration thereof) must continue
to be directed to the registered shareholder and not the Company's
registrar. The only exception is where the Company, in exercising
one of its powers under the Act, writes to nominated persons
directly for a response.
Corporate representatives
Any corporation which is a shareholder can appoint one or more
corporate representatives who may exercise on its behalf all of its
powers as a shareholder provided that, if it is appointing more
than one corporate representative, it does not do so in relation to
the same share or shares. If a corporate representative wishes to
attend the AGM in person, any such representative should bring to
the meeting written evidence of their appointment, such as a
certified copy of a board resolution of, or a letter from, the
corporation concerned confirming the appointment.
If you appoint a corporate representative and they wish to attend
the meeting electronically, they will need to contact the Company's
registrar before 11.00am London time (6.00pm Hong Kong time) on
Wednesday, 27 April 2022 to arrange for the necessary details to be
sent to them. See further details set out on pages 19 to
20.
Proxymity
If you are an institutional investor on the Principal Register in
the UK you may be able to appoint a proxy electronically via the
Proxymity platform, a process which has been agreed by the Company
and approved by the Company's registrar. For further information
regarding Proxymity, please go to www.proxymity.io. Your proxy must
be lodged by 11:00am London time (6.00pm Hong Kong time) on
Wednesday, 27 April 2022 in order to be considered valid. Before
you can appoint a proxy via this process you will need to have
agreed to Proxymity's associated terms and conditions. It is
important that you read these carefully as you will be bound by
them and they will govern the electronic appointment of your
proxy.
Shareholders' power to require circulation of
resolutions
Under section 338 and section 338A of the Act, shareholders meeting
the threshold requirements in those sections have the right to
require the Company (i) to give to shareholders of the Company
entitled to receive notice of the AGM, notice of a resolution which
may properly be moved and is intended to be moved at the AGM and/or
(ii) to include in the business to be dealt with at the AGM any
matter (other than a proposed resolution) which may be properly
included in the business. A resolution may properly be moved or a
matter may properly be included in the business of the AGM unless
(a) (in the case of a resolution only) it would, if passed, be
ineffective (whether by reason of inconsistency with any enactment
or the Company's constitution or otherwise), (b) it is defamatory
of any person, or (c) it is frivolous or vexatious. Such a request
may be in hard copy form or in electronic form, must identify the
resolution of which notice is to be given or the matter to be
included in the business of the AGM, must be authorised by the
person or persons making it, must be received by the Company not
later than six weeks before the AGM, and (in the case of a matter
to be included in the business only) must be accompanied by a
statement setting out the grounds for the request. Shareholders may
send enquiries to the Board in writing to the Group Company
Secretary and Chief Governance Officer, HSBC Holdings plc, 8 Canada
Square, London E14 5HQ, United Kingdom or by sending an email to
shareholderquestions@hsbc.com.
Shareholders' power to require website publication of audit
concerns
Under section 527 of the Act, shareholders meeting the threshold
requirements in that section may require the Company to publish on
its website a statement setting out any matter that the
shareholders propose to raise at the AGM relating to (i) the audit
of the Company's accounts (including the Auditor's report and the
conduct of the audit) that are to be laid before the AGM, or (ii)
any circumstance connected with an Auditor of the Company ceasing
to hold office since the previous meeting at which annual accounts
and reports were laid. The Company may not require the shareholders
requesting any such website publication to pay its expenses in
complying with sections 527 or 528 of the Act. Where the Company is
required to place a statement on a website under section 527 of the
Act, it must forward the statement to the Company's Auditor no
later than the time when it makes the statement available on the
website. The business which may be dealt with at the AGM includes
any statement that the Company has been required under section 527
of the Act to publish on its website.
If you have general queries about your shareholding, please contact
the relevant registrar at the address shown on page
20.
Webcast
The AGM will be webcast live at www.hsbc.com/agmwebcast and a
recording will be available for viewing for approximately two
months after the AGM. This is a view only service and does not
allow shareholders to participate in the AGM electronically.
Shareholders wishing to participate electronically are recommended
to view the webcast via the Lumi AGM website where you can also
vote and ask questions. Details on how to join are set out on pages
19 to 20 and in Appendix 8 on page 29.
Asking questions related to the business of the AGM
You have the right to ask questions in relation to the business of
the AGM but no answer need be given if (a) to do so would interfere
unduly with the preparation for the AGM or involve the disclosure
of confidential information, (b) the answer has already been given
on a website in the form of an answer to a question, or (c) it is
undesirable in the interests of the Company or the good order of
the AGM that the question be answered.
If you have any questions relating to the business of the AGM that
you would like to be addressed, please send an email to
shareholderquestions@hsbc.com referencing your Shareholder
Reference Number and we will endeavour to answer any questions
raised. We will consider all questions received and, if appropriate
and relating to the business of the AGM, give an answer at the AGM,
provide a written response or publish answers on the Company's
website at www.hsbc.com/agm.
Any questions submitted that are not relevant to the business of
the AGM will be forwarded for the attention of a relevant executive
or the registrar, as appropriate. These might include matters
relating to a shareholder's bank account or affairs which are
unlikely to be relevant to the business of the AGM.
Submitting a question in advance of the AGM does not affect your
rights as a shareholder to attend and speak at the AGM.
Shareholders attending the AGM electronically may submit questions
in writing via the Lumi AGM website or may ask questions by
telephone by following the instructions set out in the "Electronic
attendance at the 2022 Annual General Meeting" section on pages 19
to 20.
Electronic attendance at the 2022 Annual General
Meeting
You may attend the AGM electronically by accessing the Lumi AGM
website: https://web.lumiagm.com/108595130.
Accessing the AGM website
Lumi AGM can be accessed online using the latest versions of
internet browsers such as Chrome, Firefox, Edge and Safari on a PC,
laptop or internet-enabled device such as a tablet or smartphone.
If you wish to access the AGM using this method, please go to
https://web.lumiagm.com/108595130 on the day.
Logging in
On accessing Lumi AGM at the website above, you will be prompted to
enter your Shareholder Reference Number and Personal Identification
Number. These can be found printed on your form of proxy or will
have been sent to you by email if you have registered an email
address to receive electronic communications. For queries on your
Shareholder Reference Number and/or Personal Identification Number
please contact the Company's registrar using the details in the
"General information" section on page 20.
You can access the Lumi AGM website from 2.00pm London time (9.00pm
Hong Kong time) on Thursday, 28 April 2022. However, please note
that your ability to vote will not be enabled until the Chairman of
the AGM formally declares the poll open, which will take place
during the AGM.
A User Guide on how to join the AGM via the Lumi AGM website is set
out in Appendix 8 on page 29.
Duly appointed proxies and corporate representatives attending
electronically
If your investment is not held in your name on the Principal
Register or the Branch Registers (for example, it is held in a
broker account or by a custodian or nominee), it will be necessary
for you to be appointed as a proxy or corporate representative to
attend the meeting electronically. You should therefore contact the
person through which your investment is held in order to arrange
for you to be appointed as a proxy or corporate representative.
Once you have been validly appointed as a proxy or corporate
representative, you will need to contact the Company's registrar
before 11.00am London time (6.00pm Hong Kong time) on Wednesday, 27
April 2022 to arrange for you to be sent a Unique Username and
Personal Identification Number to access the Lumi AGM website. The
Unique Username can be entered in place of the Shareholder
Reference Number. Specific instructions are set out below for
non-registered shareholders in Hong Kong and for holders of
American Depositary Shares.
It is recommended that the Company's registrar is contacted as
early as possible. For corporate representatives, in relation to
shares held on the UK Principal Register or the Bermuda Branch
Register, email a scanned copy of your letter of representation to
corporate-representatives@computershare.co.uk or telephone +44 (0)
870 702 0137. In relation to shares held on the Hong Kong Branch
Register, email a scanned copy of your letter of representation to
hsbc.proxy@computershare.com.hk or telephone +852 2862 8646. For
proxy appointments, you should contact the Company's registrar to
provide your email address and details of the person through which
your investment is held. For both proxies and corporate
representatives, your Unique Username and Personal Identification
Number will be sent to you by email 24 hours prior to the
meeting.
Hong Kong non-registered shareholders
Non-registered shareholders whose shares are held in the Central
Clearing and Settlement System in Hong Kong have the option to
attend and participate at the AGM electronically. They should
liaise with their banks, brokers, custodians or nominees through
which their shares are held (together, the "Intermediary") and
provide their e-mail address to their Intermediary. The
Intermediary should register the details with HKSCC Nominees
Limited and arrange for details regarding the AGM arrangements,
including login details to access the Lumi AGM website, to be sent
by the Company's Hong Kong registrar to the e-mail addresses
provided by the non-registered shareholders. It is recommended that
instructions are sent to the Intermediary by the non-registered
shareholder as early as possible to allow time for the instructions
to be processed.
American Depositary Shares ("ADSs")
If you are a registered ADS holder (i.e. you hold your ADSs through
Computershare US, the transfer agent of the Depositary, The Bank of
New York Mellon), you will need to register in advance to attend
and participate at the AGM electronically. Please follow the
instructions on the notice that you received with your voting
instruction card.
Non-registered ADS holders: If you hold your shares through an
intermediary, such as a bank or broker, and wish to attend and
participate at the AGM electronically, you must register in advance
with Computershare US. You must submit proof of your proxy power
(legal proxy) reflecting your ADS holdings along with your name and
email address to Computershare US at legalproxy@computershare.com
or write to Computershare US, HSBC Holdings plc Legal Proxy, P.O.
Box 43001 Providence, RI 02940-3001, labelled as "Legal Proxy", and
be received no later than 5.00pm New York time, on Wednesday, 20
April, 2022 (Virtual Meeting Pre Registration and voting cut-off
Date). The details regarding the AGM arrangements, including login
details to access the Lumi AGM website, will be sent by
Computershare US to the e-mail address provided by the ADS
holder.
By providing the information required to register in advance to
attend and participate at the AGM electronically, you confirm that
you consent to the provision of such information, including any
personal data contained therein, to The Bank of New York Mellon and
Computershare US and to the further transfer by them of that
information and personal data (if applicable) to other agents of
the Company for the purpose of facilitating your attendance and
participation at the AGM electronically.
Electronic voting
Voting on all resolutions will be enabled at the AGM once the
Chairman of the AGM formally declares the poll open. Shareholders
may, at any time while the poll is open, vote electronically on any
or all of the resolutions in the Notice. Resolutions will not be
proposed individually.
Once the poll is open, the list of resolutions being put to the AGM
will appear on the Lumi AGM facility. The voting options available
will appear when you click on the voting icon. Select the option
that corresponds with how you wish to vote on each resolution:
"FOR", "AGAINST" or "WITHHELD". Once you have selected your choice,
the option will change colour and a confirmation message will
appear to indicate your vote has been cast and received - there is
no submit button.
If you make a mistake or wish to change your vote, simply re-select
the correct voting option. If you wish to "cancel" your vote,
select the "cancel" button. You will be able to change or cancel
your vote at any time whilst the poll remains open and before the
Chairman of the AGM announces its closure.
An active internet connection is required in order to successfully
cast your vote when the Chairman of the AGM commences polling on
the resolutions. It is the user's own responsibility to ensure that
they have a sufficient internet connection.
Asking questions via Lumi
Shareholders attending electronically may ask questions via the
Lumi AGM website by typing and submitting their question in
writing. To ask a question via the Lumi AGM website, you should
select the messaging icon from within the navigation bar to open
the chat box and type your question at the top of the screen. Once
finished, press the 'send' icon to the right of the message box to
submit your question.
Questions sent via the chat box on the Lumi AGM website will be
moderated before being sent to the Chairman of the AGM, in line
with the approach outlined in the "Asking questions related to the
business of the AGM" section on page 18. In some circumstance a
direct response may be given to your question via the platform,
rather than the question being put to the meeting to avoid
repetition or where the question is not relevant to the business of
the meeting.
An active internet connection is required in order to allow you to
submit questions via the Lumi AGM website. It is the user's own
responsibility to ensure that they have a sufficient internet
connection.
Asking questions via the telephone
To be able to speak at the AGM, shareholders will require the
telephone number and Conference ID which will only be accessible
once you have logged into the Lumi AGM website and completed the
registration process. The Lumi AGM website will be accessible from
2.00pm London time (9.00pm Hong Kong time) on Thursday, 28 April
2022 for telephone registration purposes. Local telephone calls
will not be charged.
Once connected you will receive further instructions on how to ask
a question. Once your call has been put through to the meeting you
will then be able to ask your question to the meeting. Questions
asked on the telephone will be answered in line with the approach
outlined in the "Asking questions related to the business of the
AGM" section on page 18.
If you join the telephone call to ask a question but are also
listening to the webcast of the AGM, please ensure the webcast is
muted, so that there is no interference between the two when
speaking.
We cannot guarantee that all shareholders that wish to ask a
question by telephone will be able to do so. If you do not think
that your question has been answered during the AGM or by other
means outside of the meeting, please send an email to
shareholderquestions@hsbc.com as outlined in the "Asking questions
related to the business of the AGM" section on page
18.
Company's registrar
For general enquiries, requests for copies of corporate
communications, or a Chinese translation of this Notice and any
future documents, please contact:
− Computershare Investor Services PLC, The
Pavilions, Bridgwater Road, Bristol, BS99 6ZZ, United Kingdom
(email via website:
www.investorcentre.co.uk/contactus);
− Computershare Hong Kong Investor Services Limited,
Rooms 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's
Road East, Hong Kong SAR (email: hsbc.ecom@computershare.com.hk);
or
− Investor Relations Team, HSBC Bank Bermuda
Limited, 37 Front Street, Hamilton HM 11, Bermuda (email:
hbbm.shareholder.services@hsbc.bm).
Holders of American Depositary Shares may obtain copies of this
document by calling +1 800 555 2470 or by writing to Proxy Services
Corporation (BNY Mellon ADR Team), 10 Drew Court - Suite #3,
Ronkonkoma, NY 11779, USA.
Information available on the website
A copy of this Notice, and other information required by section
311A of the Act, can be found on the Company's website at
www.hsbc.com/agm.
Receiving corporate communications
Shareholders may at any time choose to receive corporate
communications in printed form or to receive email notification of
their availability on the Company's website. To receive future
notifications of the availability of corporate communications on
the Company's website by email, or to revoke or amend an
instruction to receive such notifications by email, go to
www.hsbc.com/ecomms.
If you received a notification of the availability of this document
on the Company's website and for any reason have difficulty in
receiving or gaining access to the document, or you would like to
receive a printed copy of it, or if you would like to receive
future corporate communications in printed form, please write
or send an email (quoting your Shareholder Reference Number) to the
Company's registrar at the relevant address set out above. Printed
copies will be provided without charge.
Further copies of this document and future documents may also be
obtained by contacting the Company's registrar. You may amend your
election to receive corporate communications in English or Chinese
by contacting the registrar at the relevant address set out in the
'Company's registrar' section of this page.
Documents available for inspection
Copies of the following documents are available for inspection
through the Group Company Secretary and Chief Governance Officer at
the Company's registered office at 8 Canada Square, London E14 5HQ,
United Kingdom and at 1 Queen's Road Central, Hong Kong SAR during
usual business hours on any business day from the date of this
Notice until the date of the AGM (upon prior appointment only and
subject to relevant Covid-19 restrictions at the time). The
following documents will also be available at the place and
(subject to relevant Covid-19 restrictions at the time) on the date
of the AGM from at least 15 minutes before the AGM begins until the
conclusion of the AGM:
(i) the terms of appointment for the non-executive Directors and
Group Chairman, (ii) the service contracts of the executive
Directors, (iii) a copy of the share repurchase contract proposed
to be approved under Resolution 13 (the "Contract"), (iv) a list of
the proposed counterparties to the Contract, (v) a copy of the New
Articles proposed to be adopted by Resolution 17, and (vi) a copy
of the New Articles proposed to be adopted by Resolution 17 marked
up to show changes to the Current Articles. A copy of the New
Articles marked up to show changes to the Current Articles will be
available to view on the National Storage Mechanism
https://data.fca.org.uk/#/nsm/nationalstoragemechanism and,
together with a copy of the New Articles, will also be available
for inspection on the Company's website
(www.hsbc.com/agm).
Information set out in this Notice
Shareholders are advised that any telephone number, website or
email address set out in this Notice, the form of proxy or
accompanying documents should not be used for the purposes of
serving information on the Company (including the service of
documents or information relating to the proceedings at the AGM)
unless otherwise stated.
This document, for which the Directors of the Company collectively
and individually accept full responsibility, includes particulars
given in compliance with the Hong Kong Listing Rules for the
purpose of giving information with regard to the Company. The
Directors, having made all reasonable enquiries, confirm that to
the best of their knowledge and belief the information contained in
this document is accurate and complete in all material aspects and
not misleading or deceptive, and there are no other matters the
omission of which would make any statement herein or this document
misleading.
In the event of a conflict between any translation and the English
text hereof, the English text will prevail.
Directors' interests in the ordinary shares and debentures of
HSBC
Details of the interests in the ordinary shares and debentures of
HSBC of Directors who are standing for election or re-election are
set out in Appendix 7.
Appendix 1
Questions and Answers on Contingent Convertible Securities
("CCSs")
What are CCSs?
CCSs are debt securities that benefit from a particular regulatory
capital treatment under European Union and United Kingdom
legislation. CCSs will be converted or exchanged into ordinary
shares if a defined trigger event occurs. The terms of HSBC's
existing CCSs have received regulatory approval from the Prudential
Regulation Authority ("PRA").
As a banking group, HSBC must meet minimum regulatory capital
requirements in the countries in which it operates. These include
compliance with European Union and United Kingdom legislation
under which banks and bank holding companies are required to
maintain Tier 1 Capital of at least 6 per cent of their risk
weighted assets. Of that, 1.5 per cent of risk weighted assets may
be in the form of Additional Tier 1 capital. In addition, HSBC is
required to satisfy an additional capital requirement defined by
the PRA by maintaining an additional 0.6 per cent of risk weighted
assets in the form of Additional Tier 1 capital.
In order to qualify as Additional Tier 1 capital, a security must
contain certain features designed to increase the resilience of the
issuing bank should the bank's financial condition deteriorate
materially. The CCSs would qualify as Additional Tier 1 capital on
the basis that, on the occurrence of a defined trigger event, they
would be mandatorily converted into or exchanged for ordinary
shares of HSBC. The conversion or exchange would have the effect of
increasing the issuer's Common Equity Tier 1 capital
ratio.
What are the trigger events for the CCSs and what will happen if a
trigger event occurs?
Should HSBC's Common Equity Tier 1 capital ratio fall below the
defined capital trigger (the "Trigger Event"), the CCSs would be
converted into or exchanged for new ordinary shares in HSBC on
their prescribed terms. The defined capital trigger will be
specified in the terms of the CCSs when they are issued. HSBC's
existing CCSs contain a Common Equity Tier 1 capital trigger of 7.0
per cent on a non-transitional (excluding IFRS 9 transitional
arrangements) basis (the "non-transitional CET1 ratio") which has been approved
by the PRA. It is HSBC's current expectation that future CCSs
issued by the Group would contain the same capital trigger subject
to approval by the PRA.
What steps can HSBC take to mitigate a potential Trigger
Event?
HSBC is required by its regulators to have in place a recovery plan
in case its regulatory capital levels come under pressure.
Accordingly, if HSBC's capital ratios were to fall materially and
in any event in advance of a Trigger Event, HSBC would seek to
commence recovery actions in order to restore the HSBC Group's
regulatory capital ratios and reduce the likelihood of a
Trigger Event occurring. HSBC's recovery plan includes a number of
actions it may take, including reducing distributions, reducing
risk weighted assets or selling or liquidating assets.
HSBC's non-transitional CET1 ratio was 15.7 per cent as at 31
December 2021. HSBC remains a strongly capitalised bank, able to
support both organic growth and dividend returns to shareholders.
HSBC remains well placed to meet expected future capital
requirements, and will continue to take actions to remain in that
position, taking into account the evolution of the regulatory
environment. Given its current capital position and the planned
recovery actions it would take if a Trigger Event was deemed likely
to arise, HSBC considers the circumstances in which a Trigger Event
might occur in practice to be remote.
The CCSs which HSBC has issued to date have included a term which
provides that on the occurrence of a Trigger Event, the Directors
may elect, at their discretion, to give shareholders the
opportunity to purchase ordinary shares issued on conversion or
exchange of any CCSs on a pro rata basis, where practicable and
subject to applicable laws and regulations. This would be at the
same price as the holders of the CCSs would have acquired the
ordinary shares. Where permitted by law and regulation to do so,
the Company will continue to issue future CCSs including terms
which provide the Company with the discretion to offer the
opportunity to shareholders to purchase ordinary shares issued on
conversion or exchange of CCSs.
Will CCSs be redeemable?
There is no general right of redemption for the holders of the
CCSs. It is expected that HSBC would have the right to redeem the
CCSs after a minimum period of five years and in certain other
specified circumstances, but any redemption features would need to
be approved by the PRA prior to issue and any redemption would be
subject to PRA approval at the time of redemption.
Will all CCSs be in the form of Additional Tier 1
capital?
Yes. The Company has no intention to issue capital securities
pursuant to Resolutions 14 and 15 except for securities which
constitute Additional Tier 1 capital under applicable banking
regulations.
Why is HSBC seeking authority to issue CCSs?
Issuing CCSs gives HSBC greater flexibility to manage its capital
in the most efficient and economical way. It is expected that
Additional Tier 1 capital will be a cheaper form of capital than
issuing and maintaining Common Equity Tier 1 capital (e.g. ordinary
shares) to satisfy the Tier 1 Capital requirement and (provided the
Trigger Event does not occur) non-dilutive to existing
shareholders. This should improve the returns available to existing
shareholders whilst maintaining HSBC's capital strength, in line
with prevailing banking regulations.
The authorities in Resolutions 14 and 15 are required because the
Directors are only permitted to issue up to 10 per cent of the
issued ordinary share capital for cash on a non-pre-emptive basis
under the general authorisation in Resolutions 8, 9 and 10. Given
the administrative burden both in cost and time for a company the
size of HSBC to obtain these types of authorities, the Directors do
not consider it practical or in the interests of shareholders to
seek a new authority each time an issue of CCSs is proposed. It is
important to have the flexibility to react quickly to market and
regulatory demand. Furthermore, in order to obtain PRA approval to
the issuance of CCSs, all necessary allotment authorities need to
be in place, so the process of seeking a new authority in addition
to PRA approval would lead to unacceptable delay.
At what price will the CCSs be issued and how will the conversion
price be fixed?
As the CCSs are debt securities, they will be issued at or close to
their face value in a manner typical for debt securities. The terms
and conditions for the CCSs will specify a fixed conversion price
or a mechanism for setting a conversion price (which could include
a variable conversion price determined by reference to the
prevailing market price on conversion subject to a minimum "floor"
price) which will determine how many ordinary shares are issued on
conversion or exchange of the CCSs if a Trigger Event occurred. In
respect of any CCSs issued (or shares issued on conversion or
exchange of CCSs) under the authorities in Resolutions 14 and 15,
the conversion price or (as applicable) the minimum "floor"
conversion price will be agreed in advance with the PRA and will be
determined immediately prior to the issuance of such CCSs by taking
into account the following factors: (i) the lowest trading price of
HSBC's ordinary shares over the last 10 years; and (ii) market
expectations as to the conversion price, taking into account the
conversion price set for our previous Additional Tier 1 instruments
(£2.70) and the conversion prices for similar Additional Tier
1 instruments issued by our peers. The conversion price will be
subject to typical adjustments for securities of this
type.
How have you calculated the size of the authorities you are
seeking?
The size of the authorities reflected in Resolutions 14 and 15 has
been determined to provide flexibility to enable HSBC to optimise
its capital structure in light of the regulatory capital
requirements arising from the European Union and United Kingdom
legislation and PRA requirements. The authorities sought are set at
a level to provide full flexibility to the Directors to manage
HSBC's capital structure efficiently and are based on the
Directors' assessment of the appropriate amount required to enable
HSBC to hold the maximum amount of Additional Tier 1 capital taking
into account its expected risk weighted asset figures and applying
the conversion price referred to above. For this reason, the
resolutions give the Directors' authority to set the specific terms
of the CCSs after considering market practice and requirements at
the time.
Waiver granted by the Hong Kong Stock Exchange
The Hong Kong Stock Exchange has granted the Company a waiver from
strict compliance with the requirements of Rule 13.36(1) of the
Rules Governing the Listing of Securities on The Stock Exchange of
Hong Kong Limited pursuant to which the Company is permitted to
seek (and, if approved, to utilise) the authority under Resolutions
14 and 15 to issue CCSs (and to allot ordinary shares into which
they may be converted or exchanged) in excess of the limit of the
general mandate of 20 per cent of the Company's issued share
capital (the "Mandate"). The waiver has been granted on terms that
permit the Mandate, if approved, to continue in force
until:
(i)
the conclusion of the first annual general meeting of the Company
following the date on which the Mandate is approved (or the close
of business on 30 June 2023, whichever is the earlier) at which
time the Mandate shall lapse unless it is renewed, either
unconditionally or subject to conditions; or
(ii)
such time as it is revoked or varied by ordinary resolution of the
shareholders in general meeting.
Appendix 2
Purchase of Ordinary Shares by the Company
Set out below is information concerning the proposed general
mandate for the purchase of shares by the Company (Resolutions 12
and 13), which incorporates the Explanatory Statement required to
be sent to shareholders in accordance with the Hong Kong Listing
Rules as well as details of the conditional waiver granted by the
Hong Kong Stock Exchange to enable the Company to hold in treasury
any shares it may repurchase.
(a)
It is proposed that the Company be given authority to purchase up
to 2,021,399,449 ordinary shares of US$0.50 each (which represent
10 per cent of the ordinary shares in issue on 10 March 2022 being
the latest practicable date prior to the printing of this
document). Purchases of shares would be at prices not below the
nominal value of each ordinary share, US$0.50 or the equivalent in
the relevant currency in which the purchase is effected, and at not
more than 105 per cent of the average of the middle market
quotations for the ordinary shares on the London Stock Exchange for
the five dealing days before the relevant purchase or 105 per cent
of the average of the closing prices of the ordinary shares on the
Hong Kong Stock Exchange for the five dealing days before the
relevant purchase, whichever is lower.
(b)
The Directors believe that it is in the best interests of the
Company and its shareholders to have a general authority from
shareholders to enable the Company to purchase ordinary shares in
the market and to give power to the Directors to exercise such
authority. The Directors also believe that, in order for a buyback
to be completed more quickly and to allow more shareholders to
participate in any buyback, it is in the best interests of the
Company and its shareholders to have in place an authority to make
purchases of ordinary shares on the Hong Kong Stock Exchange
pursuant to an agreed form share repurchase contract. The Directors
intend that purchases of ordinary shares should only be made if
they consider that the purchase would operate for the benefit of
the Company and shareholders, taking into account relevant
factors and circumstances at that time, for example the effect
on earnings per share.
(c)
It is expected that purchases will be funded from the Company's
available cash flow or liquid resources and will, in any event, be
made out of funds legally available for the purchase in accordance
with the Articles of Association of the Company and the applicable
laws of England and Wales.
(d)
Share buybacks would not be made in circumstances where to do so
would have a material adverse effect on the capital requirements of
the Company or the liquidity levels which, in the opinion of the
Directors, are from time to time appropriate for the Company. If
the power to make purchases were to be carried out in full
(equivalent to 10 per cent of the ordinary shares in issue on 10
March 2022 being the latest practicable date prior to the printing
of this document) there might be a material adverse impact on the
capital or liquidity position of the Company (as compared with the
position disclosed in its published audited accounts for the year
ended 31 December 2021).
(e)
None of the Directors, nor, to the best of the knowledge of the
Directors having made all reasonable enquiries, any close
associates (as defined in the Hong Kong Listing Rules) of the
Directors, has a present intention, in the event that either or
both of Resolution 12 and 13 is approved by shareholders, to sell
any ordinary shares to the Company. No core connected persons (as
defined in the Hong Kong Listing Rules) of the Company have
notified the Company that they have a present intention to sell
shares in the Company to the Company or have undertaken not to sell
any of the shares in the Company held by them to the Company, in
the event that Resolutions 12 and 13 are approved.
(f)
Under the provisions of the UK Companies Act 2006 (the "Act") the
Company is permitted, following any repurchase of ordinary shares,
to retain and hold such shares in treasury. While that Act does not
impose a limit on the number of shares that a company can hold in
treasury, UK investor protection guidelines and market practice in
the UK is to limit the extent of any share purchase authority to 10
per cent of issued share capital, exclusive of treasury shares. On
19 December 2005, the Hong Kong Stock Exchange granted a
conditional waiver to the Company to enable it to hold shares which
it may repurchase in treasury (the "2005 Waiver"). The 2005 Waiver
is subject to certain conditions, including compliance by the
Company with all applicable laws and regulations in the UK in
relation to the holding of shares in treasury. As part of the 2005
Waiver, the Company has agreed with the Hong Kong Stock Exchange a
set of modifications to the Hong Kong Listing Rules necessary to
enable the Company to hold treasury shares. The modifications also
reflect various consequential matters to deal with the fact that
the Company may hold treasury shares in the future. A full version
of the modifications is available on the Company's website,
www.hsbc.com, and the Hong Kong Stock Exchange's news website,
www.hkexnews.hk. Copies of the modifications are also available
from the Group Company Secretary and Chief Governance Officer, HSBC
Holdings plc, 8 Canada Square, London E14 5HQ, United Kingdom and
the Corporation Secretary and Regional Company Secretary
Asia-Pacific, The Hongkong and Shanghai Banking Corporation
Limited, 1 Queen's Road Central, Hong Kong SAR. In accordance with
the terms of the 2005 Waiver, the Company has confirmed to the Hong
Kong Stock Exchange that it will comply with the applicable law and
regulation in the UK in relation to the holding of any shares in
treasury and with the conditions of the 2005 Waiver in connection
with any shares which it may hold in treasury.
(g)
The Directors have undertaken to the Hong Kong Stock Exchange that,
if they exercise any power of the Company to make purchases
pursuant to Resolution 12 and/or 13, they will do so in accordance
with the Hong Kong Listing Rules (as modified in accordance with
the terms of the 2005 Waiver to enable the Company to hold in
treasury any shares it may repurchase and the waiver obtained from
the Hong Kong Stock Exchange from strict compliance with Rule
10.06(2)(e) of the Hong Kong Listing Rules referred to in the notes
to Resolution 13) and the applicable laws of England and
Wales.
(h)
The Directors are not aware of any consequences which would arise
under any applicable Takeover Code as a result of any purchases
made by the Company pursuant to Resolution 12 or 13, if
approved.
(i)
As at 10 March 2022 (being the latest practicable date prior to
printing this document), the Company repurchased for cancellation
215,738,765 ordinary shares on the London Stock Exchange, BATS,
Chi-X, Turquoise and Aquis pursuant to the share buy-back which was
announced on 26 October 2021 and is ongoing. The table below
outlines the number of shares purchased and cancelled during the
ongoing buy-back programme since 26 October 2021 on a monthly
basis.
(j)
The highest and lowest mid-market prices at which ordinary shares
or, in the case of the New York Stock Exchange, American Depositary
Shares ("ADSs"), have traded on the Hong Kong, London, New York and
Bermuda Stock Exchanges during each of the twelve completed months
prior to the latest practicable date before printing of this
document are set out in the table below.
|
Share buy-back of 2021
|
|
Number of shares
|
|
Highest price paid per share£
|
|
Lowest price paid per share£
|
|
Average price paid per share£
|
|
Aggregate price paid£
|
|
Month
|
|
|
|
|
|
|
|
|
|
|
|
October 2021
|
|
5,260,011
|
|
4.4800
|
|
4.4155
|
|
4.4553
|
|
23,435,159
|
|
November 2021
|
|
66,587,296
|
|
4.4750
|
|
4.1525
|
|
4.3611
|
|
290,397,065
|
|
December 2021
|
|
48,519,407
|
|
4.5280
|
|
4.0990
|
|
4.3378
|
|
210,469,302
|
|
January 2022
|
|
25,382,519
|
|
5.2700
|
|
4.4555
|
|
4.9784
|
|
126,363,981
|
|
February 2022
|
|
19,064,151
|
|
5.5510
|
|
5.1530
|
|
5.3395
|
|
101,793,492
|
|
March 2022 (up to and including 10 March)
|
|
50,925,381
|
|
5.4040
|
|
4.4935
|
|
4.9075
|
|
249,917,525
|
|
|
Hong KongStock Exchange
|
|
London Stock Exchange
|
|
New York
Stock Exchange
(ADSs1)
|
|
Bermuda Stock Exchange
|
||||
|
|
Lowest Highest
|
|
Lowest Highest
|
|
Lowest Highest
|
|
Lowest Highest
|
||||
|
Month
|
(HK$)
|
(HK$)
|
|
(£)
|
(£)
|
|
(US$)
|
(US$)
|
|
(BD$)
|
(BD$)
|
|
March 2021
|
44.38
|
48.68
|
|
4.182
|
4.555
|
|
28.76
|
31.42
|
|
9.00
|
9.00
|
|
April 2021
|
44.83
|
48.83
|
|
4.155
|
4.543
|
|
28.63
|
31.73
|
|
7.13
|
9.00
|
|
May 2021
|
47.28
|
50.78
|
|
4.400
|
4.554
|
|
30.64
|
32.39
|
|
5.10
|
7.13
|
|
June 2021
|
44.83
|
49.73
|
|
4.173
|
4.517
|
|
28.85
|
32.07
|
|
5.10
|
9.00
|
|
July 2021
|
42.08
|
45.23
|
|
3.918
|
4.233
|
|
26.80
|
29.18
|
|
9.00
|
9.00
|
|
August 2021
|
41.43
|
44.33
|
|
3.862
|
4.127
|
|
26.44
|
28.63
|
|
5.10
|
9.00
|
|
September 2021
|
38.78
|
41.78
|
|
3.597
|
3.935
|
|
24.53
|
26.67
|
|
5.10
|
5.10
|
|
October 2021
|
40.48
|
47.83
|
|
3.842
|
4.471
|
|
26.11
|
30.72
|
|
5.10
|
5.10
|
|
November 2021
|
42.93
|
47.13
|
|
4.140
|
4.465
|
|
27.69
|
30.57
|
|
5.00
|
5.10
|
|
December 2021
|
43.53
|
46.88
|
|
4.292
|
4.494
|
|
27.85
|
30.23
|
|
5.00
|
5.00
|
|
January 2022
|
47.78
|
55.58
|
|
4.686
|
5.383
|
|
31.56
|
35.76
|
|
5.00
|
5.00
|
|
February 2022
|
54.08
|
59.28
|
|
5.138
|
5.672
|
|
34.54
|
38.25
|
|
4.95
|
5.00
|
1. Each ADS represents five ordinary shares.
Appendix 3
Amendments to Articles of Association
It is proposed to adopt new Articles of Association of the Company
("New Articles") in replacement of the current Articles of
Association of the Company ("Current Articles") with effect from
the conclusion of the AGM, principally to reflect developments in
market practice, to provide clarification and additional
flexibility where necessary or appropriate and to align with the
core shareholder protection standards set out in Appendix 3 to the
Rules Governing the Listing of Securities on The Stock Exchange of
Hong Kong Limited ("Core Protection Standards") that were
introduced on 1 January 2022.
A copy of the New Articles marked up to show changes to the Current
Articles will be available to view on the National Storage
Mechanism https://data.fca.org.uk/#/nsm/nationalstoragemechanism
and, together with a copy of the New Articles, will be available
for inspection on the Company's website (www.hsbc.com/agm) and at
the Company's registered office at 8 Canada Square, London E14 5HQ,
United Kingdom and at Queen's Road Central, Hong Kong, SAR from the
date of this Notice until the close of the AGM. They will be
available for inspection upon prior appointment only and subject to
relevant Covid-19 restrictions at the time during normal business
hours, Monday to Friday (excluding public holidays). The documents
will also be available for inspection (subject to relevant Covid-19
restrictions at the time) at the Queen Elizabeth Hall, Southbank
Centre, Belvedere Road, London SE1 8XX, on the day of the AGM from
at least 15 minutes before the AGM begins until the conclusion of
the AGM.
The principal changes to the Current Articles, which are included
in the New Articles, are summarised below. Other changes, which are
of a minor, technical or clarifying nature have not been
summarised, but are visible on the marked up copy of the proposed
New Articles. As a result of the proposed amendments, the numbering
of provisions in the New Articles does not always correspond to the
Current Articles and references to an Article are references to the
relevant Article in the proposed New Articles unless otherwise
stated.
Interpretation
To modernise the Current Articles and reflect the way that the
Company communicates with shareholders in practice, references to
"writing or written" in the New Articles now include documents in
electronic form (Article 2.1).
The definition of "electronic facility" has been updated to reflect
changes to market practice (Article 2.1) and a provision has been
included to elaborate on what it means for a person to "speak" and
"be heard" (Article 2.2(g)). This is discussed further under
"Hybrid meetings" below.
There is a general provision in the New Articles confirming that,
unless otherwise provided for in the UK Companies Act 2006 (the
"Act") or the New Articles, the powers of the Company or the
Directors (or any person to whom they have delegated their powers)
to exercise a discretion or take a decision confers a right to
exercise it in such a way as they in their absolute discretion
think fit (Article 2.2(h)). This replaces a range of specific
provisions to that effect in individual articles in the Current
Articles.
Gender neutral
The language used throughout the New Articles has been updated to
be gender neutral - for example, by replacing "he" or "she" with
"they", "him" or "her" with "them" and "Chairman" with
"Chair".
Hybrid meetings
The provisions in the Current Articles relating to hybrid general
meetings have been supplemented to reflect changes in market
practice for hybrid meetings and the experience of holding meetings
during the Covid-19 pandemic. A provision has been included in the
interpretation section expanding on what it means for a person to
"speak" and "be heard" at a meeting (Article 2.2(g)). This provides
the Company with greater flexibility to conduct the meeting and
facilitate shareholder participation using all forms of technology
available. A provision has also been included dealing with the
appointment of a replacement Chair of a general meeting if the
original Chair is participating electronically and the facilities
the original Chair is using fail, whether temporarily or otherwise
(Article 59.2). In addition, certain consequential amendments have
been made to the New Articles that are in line with market practice
(Articles 54.7 and 75.1).
Board's right to postpone or change general meeting
arrangements
The postponement provisions have been amended to give the Company
greater flexibility to change the arrangements of the meeting if
the Directors consider it impracticable, undesirable or
unreasonable to hold the meeting in the way originally envisaged.
In addition to the Board's existing ability to change the date,
time or place of, or electronic facilities being used at, the
general meeting, the Company may introduce electronic facilities or
make any other alterations in respect of the meeting (Article 56).
These changes give the Company greater flexibility to adapt to
changing circumstances such as those experienced during the
Covid-19 pandemic.
The New Articles also provide that the Board may consider the
health, as well as the safety, of attendees when determining or
changing the arrangements of a general meeting (Article 64.1). This
is another change driven primarily by the Covid-19 pandemic and
gives the Company greater flexibility to take measures to protect
the health of its shareholders.
Untraceable shareholders
The New Articles provide the Company with additional flexibility in
dealing with untraced shareholders and rights in relation to the
sale of shares owned by shareholders who are untraced after a
period of 12 years.
Under the Current Articles, the Company is required to give notice
to untraced shareholders of an intention to sell their shares by
way of a newspaper advertisement and give notice of its intention
to sell such shares to any exchange that the shares of the
concerned class were listed on. The New Articles provide that the
Company must instead send a final notice in hard copy to the last
known physical address of the shareholder or in electronic form to
the last known email address of the shareholder that the Company
has and use such reasonable efforts as the Company considers
appropriate to trace the shareholder (Article 85.1). This change
reflects market practice and safeguards shareholder rights while
not placing unduly onerous obligations on the Company and provides
the Company with appropriate flexibility in connection with
locating untraced shareholders.
Director share qualification
To reflect changes in best practice and to align with the
requirements set out in the Directors' Remuneration Policy, Article
92 of the Current Articles has been deleted in the New Articles.
Article 92 of the Current Articles provides that a Director shall
not be required to hold any shares of the Company. The inclusion of
provisions relating to shareholding qualifications in articles of
association is no longer common practice and is not legally
required under the Act. A consequential amendment has also been
made to Article 99.3 of the New Articles in relation to alternate
Directors.
The shareholding guidelines which Directors are expected to satisfy
can be found on pages 261 and 265 of the Directors'
Remuneration Policy in the Annual Report and Accounts for the
year ended 31 December 2021.
Deemed re-appointment of Directors where number of Directors falls
below minimum through vacancies
Under the Current Articles, a Director who fails to be re-elected
at an annual general meeting will remain in office until the end of
the meeting or (if earlier) upon the election of someone else to
replace them. Under the New Articles, if the number of Directors at
the end of the annual general meeting is fewer than the required
minimum number of Directors prescribed under Article 87, all
retiring Directors will be deemed re-appointed as Directors but
shall only be able to act for limited purposes (Articles 95.2 and
95.3). A general meeting shall be convened as soon as reasonably
practicable following that meeting, at which the retiring Directors
will retire if the number of Directors appointed or ratified at the
subsequent meeting is equal to or above the required
minimum.
Inspection of Hong Kong Overseas Branch Register
Article 118.5 has been included in the New Articles and provides
that, without prejudice to any rights of inspection under the Act,
the Hong Kong Overseas Branch Register may be inspected in Hong
Kong by shareholders free of charge or by any other person on
payment of the prescribed fee in accordance with Section 1167 of
the Act. This conforms with the requirements set out in paragraph
20 of the Core Protection Standards.
Directors' written resolutions
Article 127 of the Current Articles has been replaced by Article
126 of the New Articles, which seeks to provide flexibility to the
Board and reflect changes in working practice. Under Article 126 of
the New Articles, a Director may indicate their agreement to a
proposed Directors' written resolution by signing one or more
copies of it or otherwise indicating their agreement in
writing.
Distribution in specie
Article 148 of the New Articles reflects amendments in line with
market practice to give the Company the ability to decide that all
or part of any dividends or other distributions in respect of a
share may be made by distributing non-cash assets of any kind,
including shares, debentures or other securities of another
company.
Forfeiture of related dividends following exercise of power of
sale
The New Articles also contain related changes in respect of
unclaimed dividends or other sums payable on the shares of untraced
shareholders which are sold pursuant to Article 85. Article 152.2
of the New Articles provides that, if the Company exercises the
power of sale in respect of any share of an untraced shareholder,
any dividend payable in respect of the share which is outstanding
at that time will be forfeited and cease to remain owing by the
Company. The Company may use those forfeited dividends or other
sums for such good causes as the Company thinks fit.
Payment of scrip dividends
The New Articles give an express power to the Directors to
determine, in relation to any scrip dividend, how the relevant
costs will be met, the minimum number of Ordinary Shares required
to be held by a shareholder in order to be able to participate and
any arrangements required to deal with legal and practical
difficulties in any particular territory (Article
153).
Notices by advertisement and suspension of postal
services
Article 169 of the Current Articles provides that any notice to be
given by the Company to shareholders (that is not otherwise
provided for in the Current Articles) can be given by way of
newspaper advertisement only. This provision has been amended in
the New Articles to give the Board additional flexibility such that
any notice to be given, sent or supplied by the Company (not being
a notice of general meeting or a notice or document covered by the
requirements of the Act) will be sufficiently given, sent or
supplied to shareholders advertised by such means as the Board may
determine (including, but not limited to, by way of newspaper
advertisement) (Article 167).
The change to Article 167 in the New Articles results in
consequential amendments to Article 168 of the New Articles, which
deals with the suspension or curtailment of postal services within
the United Kingdom or Hong Kong resulting in the inability to
convene a general meeting by post. Article 168 of the New Articles
reflects updates in line with market practice and provides the
Company with the flexibility to give notice of a general meeting to
shareholders by way of electronic communication to those
shareholders that have provided the Company with an address for
this purpose. Any electronic communication will be in addition to
newspaper advertisements and an advertisement on the Company's
website.
Dispute resolution
The Company is incorporated in England and Wales and its Articles
of Association are governed by English law. Although the Company's
shareholders are predominantly based in the United Kingdom or Hong
Kong, the Company has a wide international shareholder base. If
Resolutions 17(a) and 17(b) are passed, Article 171 will be
included in the New Articles to require certain disputes involving
shareholders of the Company and the Company, and/or its current or
former directors, officers or employees (including, in summary,
disputes under the Articles, derivative claims brought by
shareholders on behalf of the Company and claims for breach of a
fiduciary or other duty owed to the Company or its shareholders) to
be brought in the courts of England and Wales or Hong Kong. The
Board considers that these courts are the most appropriate fora for
adjudicating these types of claims, due to their experience of
dealing with English law principles, as well as companies
incorporated in England and Wales. If these types of claims were to
be brought in other courts, the Company and/or its current or
former directors, officers or employees may become drawn into
litigation involving foreign legal principles in courts that are
not as accustomed to dealing with English law-related questions.
The proposed Article 171 seeks to minimise this risk. Article 171
also applies to such claims involving subsidiaries of the Company
and/or current or former directors, officers or employees of those
subsidiaries.
Appendix 4
New Article 171
171 Dispute resolution
171.1 Unless the Company consents in writing to the selection of an
alternative court, (i) any dispute between a member in that
member's capacity as such and the Company and/or any current or
former director, officer or employee of the Company arising out of
or in connection with these Articles or otherwise; (ii) any
derivative action or proceeding brought on behalf of the Company;
or (iii) any action asserting a claim of breach of a fiduciary or
other duty owed by any current or former director, officer or
employee of the Company to the Company or the Company's members,
may only be brought in the courts of England and Wales or Hong
Kong, and not in any other court. Damages alone may not be an
adequate remedy for breach of this Article 171.1 and, as a result,
in the event of breach or anticipated breach of this Article 171.1,
the remedies of injunction and/or order for specific performance
would be appropriate. The Company may enforce this Article 171.1
for its own benefit or, to the extent that it, in its absolute
discretion, sees fit, for the benefit of any other person,
including, without limitation, a current or former director,
officer or employee or a subsidiary.
171.2 For the purposes of this Article 171 only, "Company" means
HSBC Holdings plc and each and any of its subsidiaries from time to
time.
Appendix 5
Explanatory statement supplied by the Midland Clawback Campaign
Shareholder group in support of the requisitioned Resolution
19
We have commissioned two law schools to complete independent
academic research, with the expectation it will show how an
outdated law, unfit for purpose in today's enlightened society,
disparately impacts the very workers, that it was meant to protect
from financial disadvantage.
The investigators commissioned to undertake research into "State
Deduction" are:-
Dr James Kolaczkowski, Bristol Law School, University of the West
of England.
James began his career in London and practised as a solicitor at a
commercial law firm in Bristol specialising in pensions. He is the
Business and Law Clinic departmental lead, and completed PhD
research considering the role of the European Union in Occupational
Pensions in the UK. His current research interests cover fiduciary
duties, governance and regulation, particularly in the context of
pension's law and policy, from both commercial and social
perspectives. James is a Fellow of the Higher Education Academy and
a member of the Society of Legal Scholars and the European Network
for Research on Supplementary Pensions.
&
Dr David Barrett, Exeter Law School, University of
Exeter.
David joined Exeter Law School in September 2018 and has two
primary research interests: (i) socio-economic rights and
socio-economic inequality (particularly within the UK context); and
(ii) mechanisms of equality and human rights enforcement beyond
courts.
David is a member of the Economic and Social Rights Academic
Network: UK and Ireland (ESRAN-UKI) and the Socio-Legal Studies
Association (SLSA) and is one of the convenors for the 'Equality
and Human Rights' stream at the SLSA Annual
Conference.
The investigators are reviewing what little relevant literature and
case law exists, with a focus upon the equality law position (i.e.
the impact upon certain types of scheme member) and the issue of
legitimate expectations (i.e. the fact that scheme members receive
less than they were expecting).
This will develop a theoretical framework with which to interrogate
the research questions. It is intended that this will be supported
by interviews with scheme members and a review of the documentation
such as communications with scheme members.
The investigators will write an academic article addressing the
issue of clawback for submission to peer review and publication in
an academic journal. The paper will be drafted during the first
year of work, further developed following academic presentation and
review, and then submitted for publication in academic journals.
Publication is anticipated during the second year of the
project.
The investigators will aim to widely disseminate the results by
presenting at seminars, workshops/ conferences, or by organising
and hosting specific events, via their academic and professional
networks.
Appendix 6
The Board's response to Resolution 19 requisitioned by the Midland
Clawback Campaign Shareholder group
Your Directors consider that Resolution 19 is not in the best
interests of the Company and its shareholders as a whole and
unanimously recommend that you vote AGAINST Resolution 19 for the
reasons set out below:
HSBC's position on the removal of the State Deduction feature has
been consistent; that it would constitute a retrospective change
that would benefit a particular group of members and would be
unfair to other HSBC Bank (UK) Pension Scheme ("Scheme") members.
It would increase the risk of grievances being raised from other
pension scheme members both in the UK and globally and would set a
precedent for further challenges to pre-existing valid terms and
conditions that could lead to significant unplanned and unintended
costs.
The term State Deduction is a common term used to describe the
integration of private and state benefits and was clearly and
consistently communicated to members.
HSBC commissioned a market review of the State Deduction feature in
the third quarter of 2020. The review demonstrated that integration
of private sector pension schemes with state benefits, to target an
overall level of benefit, remains an accepted and common aspect of
UK pensions practice.
The use of State Deduction as a mechanism of integrating Scheme and
state benefits is recognised by current legislation and continues
to be maintained by a significant number of schemes. The Equality
and Human Rights Commission (the "EHRC") has confirmed that the use
of State Deduction is lawful.
HSBC has been engaged in addressing questions on the State
Deduction feature over several years. This has included protracted
correspondence with the members of the Post 1974 Midland Section of
the Scheme (the "Campaign Group"). The Campaign Group has also
proposed resolutions relating to State Deduction at the last three
AGMs all of which have been voted down by shareholders. The
Campaign Group has now advised that it wishes to commence an
academic study to examine the lawfulness and fairness of the State
Deduction. This will be undertaken by the Campaign Group's
appointed legal academics. The Campaign Group is seeking the
Company's participation in this research. The intention is that the
subsequent findings would then form the basis for additional
discussions between the Company and the Campaign Group. However, we
believe this issue has already been subject to extensive
consideration involving legal advice from leading counsel;
consideration and rejection of the Campaign Group's claim by the
EHRC; independent legal advice from the Trustee's counsel; the 2020
market review and on-going consideration of this issue at three
previous AGMs. Consequently, in our view, the Company's engagement
in the proposed research would only duplicate work that has already
been undertaken and concluded.
The Campaign Group has a specific concern over how and when Scheme
members were advised of the State Deduction. Such advice is the
responsibility of the Scheme Trustee. The Trustee, which is
independent of the Company, provided the Campaign Group with
detailed advice in 2017 following an extensive review of the
Scheme's documentation. This evidenced that members were correctly
advised of the State Deduction over several decades and in
accordance with the relevant regulations. As such any further
research into this aspect would simply involve duplication of work
that has already been undertaken and concluded. We believe that by
continuing to apply the State Deduction we are acting correctly and
lawfully, particularly when consideration is given to both the
broader HSBC pensioner and employee population, many of whom do not
receive a final salary pension, and the broader wider market
practice for pension schemes of this type.
This position is taken having consulted with the Trustees of the
Scheme and having taken external advice.
Background:
What is the Post 1974 Midland Section?
All employees who joined HSBC Bank plc (or Midland Bank plc at the
time) after 31 December 1974 and before 1 July 1996 were eligible
to join the Post 1974 Midland Section (the "Post 1974 Section") of
the Scheme. The Post 1974 Section provides final salary benefits
and was non-contributory until 2009. It was designed to ensure that
members received an overall pension of broadly two-thirds of final
salary on retirement (provided they worked for the company for 40
years).
The Post 1974 Section consists of approximately 52,000 members. The
State Deduction feature applies to all members of this section of
the Scheme.
The Post 1974 Section has been closed to new members since July
1996. New joiners of the HSBC Group in the UK are now enrolled into
the defined contribution section of the Scheme, which does not
provide a guaranteed income on retirement.
What is the State Deduction?
The State Deduction is one of a number of recognised mechanisms
used to facilitate the integration of Scheme and state benefits and
has been a feature of the Post 1974 Section since its introduction
in 1975. The State Deduction takes account of the fact that
employees would usually receive a pension from the UK Government at
their State Pension Age, and reduces the amount paid by the Scheme
at State Pension Age. The aim was that members would continue to
receive an overall pension level throughout retirement (subject to
minimum employment terms and pension increases). This form of
integration with the State system was a common feature in final
salary schemes introduced at that time.
What is "Clawback"?
Clawback is a term used by the Campaign Group to refer to the State
Deduction.
"Clawback" is not an accurate description of the State Deduction.
HSBC agreed to provide pension benefits to members and fund the
scheme on the basis that the State Deduction will be applied. No
aspect of members' benefits, or amounts paid to members, are or
will be clawed back, nor are they "withheld".
HSBC's position:
When the Scheme was introduced, it required no contribution from
members to secure an overall pension of up to two-thirds of final
salary on retirement.
When joining HSBC, employees were automatically enrolled in the
Scheme and the Scheme literature expressly highlighted that the
integration of state pension would be part of their pension
calculation.
Features akin to the State Deduction were commonplace in other
pensions as well as other sections of the Scheme.
When the State Deduction was introduced, many schemes integrated
state and scheme benefits in various ways to target overall levels
of benefit.
Survey results of 140 pension schemes, commissioned by HSBC in
2020, show that integration of state and private sector scheme
pension benefits remains very common, with almost two thirds of
participants having some form of state pension integration. This
proportion increases further when comparing financial services
participants (71%) and even greater when comparing large financial
services sector schemes of similar size to the HSBC scheme (88%).
This is more apparent when the distinction between public and
private sector schemes is made and when schemes are considered by
reference to industry sector, being financial services, and
size.
The State Deduction is common terminology for similar integration
features amongst other schemes, and was clearly and consistently
communicated to members.
HSBC commissioned a thorough review of how the State Deduction was
communicated to members dating back to its introduction in 1975 to
determine if HSBC made the Post 1974 Section's members sufficiently
aware of the feature. HSBC's legal advisers have determined that
the State Deduction was clearly and consistently communicated
within Scheme communications. The Scheme Trustee, who is separate
to and independent of HSBC, also carried out an extensive review of
Scheme documents and correspondence from its introduction in 1975
to date and concluded that the deduction was communicated in a
transparent manner.
The EHRC has confirmed that the use of the State Deduction is
lawful.
HSBC was contacted by the EHRC in late 2018 on an informal basis
concerning the State Deduction. In the course of that
correspondence HSBC provided a detailed analysis of the background,
rationale and legal basis on which the State Deduction operates.
This included advice from leading Counsel. Following review of the
information provided, the EHRC has now confirmed that the use of
the State Deduction is lawful.
The State Deduction forms part of the pension benefit calculation
for all members of the Post 1974 Section. It does not put members
who share a particular characteristic, such as gender, at a
disadvantage. The extent to which the State Deduction forms a
greater or lesser proportion of an individual's pension depends on
the size of their total pension, which will also depend on a number
of factors. Members with a lower final pensionable salary will
receive a lower pension than those on a higher final pensionable
salary (assuming the same period of service). In the same way if a
member retires early, or takes a lump sum, then the residual
pension will also be lower resulting in the State Deduction forming
a higher proportion of overall pension.
Removal of the State Deduction would be unfair to other Scheme
members.
Removal of the State Deduction would constitute a retrospective
change which would benefit a particular group of members and be
unfair to other Scheme members. It would increase the risk of
grievances being raised from other pension scheme members both in
the UK and globally and would set a precedent for further
challenges to valid terms and conditions that could lead to
significant unplanned and unintended costs.
The results of our most recent survey show that very few schemes
have retrospectively amended any elements of integration with the
State Pension, beyond dealing with changes to State Pension Age or
the structure of the State Pensions. In particular, it showed that
no schemes in the survey with a similar feature to the State
Deduction have removed this retrospectively on the grounds of it
being considered unfair or inappropriate.
HSBC has continuously engaged in addressing questions on the State
Deduction
HSBC has been continuously engaged over several years in addressing
questions on the State Deduction and on occasion this has involved
face to face meetings. Such meetings may be appropriate if or when
any new aspect of this issue is presented but not when this will
involve addressing queries that have already been answered or
settled (for example by the EHRC). HSBC has continued to respond to
all correspondence and provide answers where appropriate.
Consistent with this approach in November 2021 further detailed
written advice was provided to queries presented by the All Party
Parliamentary Group (the "APPG") involved with the Campaign Group.
This advice explained the accepted legal position and the
associated facts relevant to aspects of the State Deduction. An
offer of a subsequent bi-lateral meeting was also extended to the
Chair of the APPG should any clarification be
required.
Appendix 7
Directors' interests in the ordinary shares and debentures of
HSBC
According to the register of Directors' interests maintained by the
Company pursuant to section 352 of the Securities and Futures
Ordinance of Hong Kong, the Directors who are standing for election
or re-election had the interests set out in the table below, all
beneficial unless otherwise stated, in the shares and debentures of
HSBC and its associated corporations on the latest practicable date
prior to the printing of this document being 10 March
2022.
In this Appendix, all references to "beneficial owner" means a
beneficial owner for the purposes of the Securities and Futures
Ordinance of Hong Kong.
Notifications of major holdings of voting rights
During 2021 and as at 10 March 2022 (the latest practicable date
prior to printing this document), the Company did not receive any
notifications of major holdings of voting rights pursuant to the
requirements of the UK Financial Conduct Authority's Disclosure
Guidance and Transparency Rules. Previous notifications received
are as follows:
− BlackRock, Inc. gave notice on 3 March 2020 that
on 2 March 2020 it had the following: an indirect interest in HSBC
Holdings ordinary shares of 1,235,558,490; qualifying financial
instruments with 7,294,459 voting rights that may be acquired if
the instruments are exercised or converted; and financial
instruments with a similar economic effect to qualifying financial
instruments, which refer to 2,441,397 voting rights, representing
6.07%, 0.03% and 0.01%, respectively, of the total voting rights at
2 March 2020.
− Ping An Asset Management Co., Ltd. gave notice on
6 December 2017 that on 4 December 2017 it had an indirect interest
in HSBC Holdings ordinary shares of 1,007,946,172, representing
5.04% of the total voting rights at that date.
The following notifications of major holdings have been made to the
Company and have not been amended or withdrawn, as at 10 March
2022, the latest practicable date prior to printing this document,
pursuant to the requirements of section 336 of the Securities and
Futures Ordinance of Hong Kong:
− BlackRock, Inc. gave notice on 9 March 2022 that
on 4 March 2022 it had the following interests in HSBC Holdings
ordinary shares: a long position of 1,701,656,169 shares and a
short position of 19,262,061 shares, representing 8.27% and 0.09%,
respectively, of the ordinary shares in issue at that
date.
− Ping An Asset Management Co., Ltd, gave notice on
25 September 2020 that on 23 September 2020 it had a long position
of 1,655,479,531 in HSBC Holdings ordinary shares, representing
8.00% of the ordinary shares in issue at that
date.
|
HSBC Holdings plc ordinary shares
|
|
Beneficial
owner
|
|
Child
under 18
or spouse
|
|
Jointly
with
another
person
|
|
Trustee
|
|
Total
interests
|
|
Rachel Duan
|
|
-
|
|
-
|
|
-
|
|
-
|
|
-
|
|
Dame Carolyn Fairbairn
|
|
-
|
|
-
|
|
-
|
|
-
|
|
-
|
|
James Forese1
|
|
115,000
|
|
-
|
|
-
|
|
-
|
|
115,000
|
|
Steven Guggenheimer1
|
|
-
|
|
-
|
|
15,000
|
|
-
|
|
15,000
|
|
Dr José Antonio Meade Kuribreña1
|
|
15,000
|
|
-
|
|
-
|
|
-
|
|
15,000
|
|
Eileen Murray1
|
|
75,000
|
|
-
|
|
-
|
|
-
|
|
75,000
|
|
David Nish
|
|
-
|
|
50,000
|
|
-
|
|
-
|
|
50,000
|
|
Noel Quinn2
|
|
1,209,595
|
|
-
|
|
-
|
|
-
|
|
1,209,595
|
|
Ewen Stevenson2
|
|
886,326
|
|
-
|
|
-
|
|
-
|
|
886,326
|
|
Jackson Tai1,3
|
|
32,800
|
|
11,965
|
|
21,750
|
|
-
|
|
66,515
|
|
Mark E Tucker
|
|
307,352
|
|
-
|
|
-
|
|
-
|
|
307,352
|
1. James
Forese has an interest in 23,000, Steven Guggenheimer has an
interest in 3,000, Dr José Antonio Meade Kuribreña has an
interest in 3,000, Eileen Murray has an interest in 15,000 and
Jackson Tai has an interest in 13,303 listed American Depositary
Shares ("ADS"), which are categorised as equity derivatives under
Part XV of the Securities and Futures Ordinance of Hong Kong. Each
ADS represents five HSBC ordinary shares.
2.
Executive Directors' other interests in HSBC ordinary shares
arising from the HSBC Savings-Related Share Option Plan (UK) and
the HSBC Share Plan 2011 are set out in the Scheme interests in the
Directors' remuneration report on pages 273 to 274 of the 2021
Annual Report & Accounts. At 10 March 2022, the aggregate
interests under the Securities and Futures Ordinance of Hong Kong
in HSBC ordinary shares, including interests arising through
employee share plans and the interests above were: Noel Quinn -
3,793,122; and Ewen Stevenson - 3,080,697. Each Director's total
interests represents 0.02% of the shares in issue and 0.02% of the
shares in issue excluding treasury shares.
3.
Jackson Tai has a non-beneficial interest in 11,965 shares of
which he is custodian.
Appendix 8
Online User Guide to the Lumi Platform
If you choose to attend the AGM electronically, you will be able to
view a live webcast of the meeting, ask the Board questions and
submit your votes in real time. You will need to visit
https://web.lumiagm.com/108595130 on your smartphone, tablet or
computer. You will need the latest versions of Chrome, Safari, Edge
or Firefox. Please ensure your browser is compatible.
Meeting ID: 108-595-130
To login you must have your Shareholder Reference Number and
PIN
|
1.
On the day of the AGM, open the Lumi AGM website using the URL
https://web.lumiagm.com/108595130.
Note: Access to the Lumi AGM website will be available from 2.00pm
London time (9.00pm Hong Kong time) on Thursday, 28 April 2022 to
register for the telephone service - see step 3 below.
|
|
|
2
You will be prompted to enter your unique Shareholder Reference
Number ("SRN") and PIN. This would be on your Proxy
Card.
Note: Proxies and corporate representatives will need to obtain a
Unique Username and PIN from the registrar in order to be able to
access the Lumi AGM website - see page 19. The Unique Username
should be entered in place of the SRN.
|
|
|
3.
When successfully authenticated, you will be taken to the Home
Screen.
Note: If you wish to use the telephone service, the details will
appear in this section of the website. Please follow the
instructions in order to be able to access the telephone service.
Registration for the telephone service will be available from
2.00pm London time (9.00pm Hong Kong time) on Thursday, 28 April
2022.
|
|
|
4.
The meeting presentation will appear automatically once the meeting
commences. If you wish to expand the broadcast click the full
screen button, located in the top right corner, if you wish to exit
from the full screen view click the 'X' located in the top right
corner.
|
|
|
5.
When the Chairman declares the poll open, a list of all resolutions
and voting choices will appear on your device. Scroll through the
list to view all resolutions.
|
|
|
6.
For each resolution, press the choice corresponding with the way in
which you wish to vote. When selected, a confirmation message will
appear. If you prefer, you may cast your votes on all resolutions
at the same time by clicking the direct button at the top of the
list, you may still change your mind on individual items if
required.
|
|
|
7.
To change your mind, simply press the correct choice to override
your previous selection. To cancel your vote, press Cancel. To
return to the voting screen whilst the poll is open, select the
voting icon.
|
|
|
8.
If you would like to ask a question, select the messaging icon.
Type your message within the chat box at the top of the messaging
screen. Click the send button to submit.
|
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
HSBC
Holdings plc
|
|
|
|
|
|
|
By:
|
|
|
Name:
Aileen Taylor
|
|
|
Title:
Group Company Secretary and Chief Governance Officer
|
|
|
|
|
|
Date:
25 March 2022
|